-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, U7sV1FtThf7r6Ks50lYvOg0mS/gOu4/VjupiDqlGjCwe0aafJ6fvT1AYACjXa3Op CP6zMQixY/DM0Z3IdPPZNg== 0001122304-08-000016.txt : 20080207 0001122304-08-000016.hdr.sgml : 20080207 20080207063731 ACCESSION NUMBER: 0001122304-08-000016 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20080207 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20080207 DATE AS OF CHANGE: 20080207 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AETNA INC /PA/ CENTRAL INDEX KEY: 0001122304 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 232229683 STATE OF INCORPORATION: PA FISCAL YEAR END: 0427 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-16095 FILM NUMBER: 08583079 BUSINESS ADDRESS: STREET 1: 151 FARMINGTON AVENUE CITY: HARTFORD STATE: CT ZIP: 06156 BUSINESS PHONE: 8602730123 MAIL ADDRESS: STREET 1: 151 FARMINGTON AVENUE CITY: HARTFORD STATE: CT ZIP: 06156 FORMER COMPANY: FORMER CONFORMED NAME: AETNA U S HEALTHCARE INC DATE OF NAME CHANGE: 20000822 8-K 1 form8-k.htm AETNA FORM8-K form8-k.htm



                                                                                                                                           & #160;        

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):
February 7, 2008
 
Aetna Corporate Logo

Aetna Inc.
(Exact name of registrant as specified in its charter)


Pennsylvania
1-16095
23-2229683
(State or other jurisdiction of
(Commission
(IRS Employer
incorporation)
File Number)
Identification No.)

151 Farmington Avenue, Hartford, CT
06156
(Address of principal executive offices)
(Zip Code)

Registrant’s telephone number, including area code:
(860) 273-0123

Former name or former address, if changed since last report:
Not applicable

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 




 
Section 2 – Financial Information

Item 2.02   Results of Operations and Financial Condition.

On February 7, 2008, Aetna Inc. issued a press release announcing results for the fourth quarter and full-year ended December 31, 2007.  A copy of that press release is furnished herewith as Exhibit 99.1 and hereby incorporated in this Item 2.02 by reference.

The information in this Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (as amended, the “Exchange Act”) or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.


Section 9 – Financial Statements and Exhibits

Item 9.01   Financial Statements and Exhibits.

(d) Exhibits.

 
99.1
Press release of Aetna Inc. dated February 7, 2008 announcing results for the fourth quarter and full-year ended December 31, 2007.



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
Aetna Inc.

 Date:  February 7, 2008
By:
 /s/ Ronald M. Olejniczak   
   
Name: Ronald M. Olejniczak
 
 
Title: Vice President and Controller





 

Exhibit
Number
Description
   
Exhibit 99.1
Press release of Aetna Inc. dated February 7, 2008 announcing results for the fourth quarter and full-year ended December 31, 2007.









EX-99.1 2 ex99.htm AETNA PRESS RELEASE ex99.htm

Exhibit 99.1

151 Farmington Avenue
Hartford, Conn.  06156
Media Contact:
Fred Laberge
860-273-4788
labergear@aetna.com
   
Investor Contact:
Jeffrey A. Chaffkin
860-273-7830
chaffkinj@aetna.com

News Release _________________________________________________________

     AETNA REPORTS FOURTH-QUARTER AND FULL-YEAR 2007 RESULTS
·
Fourth-quarter operating earnings were $0.88 per share, a 13 percent increase over the prior-year quarter, in line with the Thomson/First Call mean of $0.88 per share
·
Fourth-quarter net income was $0.87 per share, a 9 percent increase over the prior-year quarter
·
Full-year 2007 operating earnings were $3.49 per share, a 20 percent increase over 2006
·
Full-year net income was $3.47 per share, a 16 percent increase over 2006
·
Commercial Medical Benefit Ratio was 79.2 percent for fourth quarter 2007 and 79.5 percent for the full year
·
Medical membership grew organically by 168,000 in the fourth quarter 2007 and 730,000 for the full year; overall medical membership was 16.853 million including members in the Schaller Anderson and Goodhealth Worldwide acquisitions
·
Guidance: Full-year 2008 operating earnings per share projected to be $4.00; first-quarter 2008 operating earnings per share projected to be $0.92

HARTFORD, Conn., February 7, 2008― Aetna (NYSE: AET) today announced fourth-quarter 2007 operating earnings of $0.88 per share.  The increase in operating earnings per share reflects 12 percent total revenue growth, primarily from quarter-over-quarter membership growth and premium and fee rate increases, as well as solid underwriting results and continued general and administrative expense efficiencies.  This improvement also reflects the benefit of continued share repurchases.  Fourth-quarter net income was $0.87 per share, an increase of 9 percent over the prior-year quarter.  Operating earnings exclude net realized capital gains (losses) and other items. (1)

Full-year 2007 operating earnings increased by 20 percent over the prior year to $3.49 per share.  Net income was $3.47 per share, an increase of 16 percent over the prior year.


Aetna/2

Quarterly Financial Results at a Glance
 
                   
   
Three Months Ended December 31,
 
(Millions, except per share results)
 
2007
   
2006
   
Change
 
Total revenue
  $ 7,144.4     $ 6,359.5       12 %
Operating earnings(1)
    454.5       424.2       7 %
Net income
    448.4       434.1       3 %
                         
Per share results:
                       
Operating earnings(1)
    .88       .78       13 %
Net income
    .87       .80       9 %
                         
Weighted average common shares - diluted
    516.3       541.8          

Full-Year Financial Results at a Glance
 
                   
   
Twelve Months Ended December 31,
 
(Millions, except per share results)
 
2007
   
2006
   
Change
 
Total revenues
  $ 27,599.6     $ 25,145.7       10 %
Operating earnings(1)
    1,837.1       1,647.9       11 %
Net income
    1,831.0       1,701.7       8 %
                         
Per share results:
                       
Operating earnings(1)
    3.49       2.90       20 %
Net income
    3.47       2.99       16 %
                         
Weighted average common shares - diluted
    527.0       569.1          

 “We are very pleased to have delivered another year of strong results in 2007,” said Ronald A. Williams, chairman and CEO. “Our disciplined focus on providing innovative products, integrated solutions and best-in-class customer service has resulted in consistent, profitable growth and a platform for continued success in 2008.

“These accomplishments have been the direct result of the execution of our strategy, the efforts of our dedicated workforce and our unwavering focus on the people who use our services.  Continued growth across product lines; our ongoing work to identify and reach underserved segments of the marketplace; and broadening our product portfolio, whether through recent acquisitions or innovation, have positioned Aetna well for future growth.  It is through the combination of all of these factors, as well as targeting our growth by better understanding the needs of our customers through market segmentation, that we will attain industry leadership. That’s our goal.”


Aetna/3

“Aetna’s excellent results in 2007 validate our winning strategy,” said Joseph M. Zubretsky, executive vice president and CFO. “We continue to effectively manage medical costs, to increase our membership and revenues and to effectively deploy capital, three keys to delivering sustained profitable growth.

“For full-year 2008, we project operating earnings to be $4.00 per share, in line with our prior guidance.  We project our first-quarter 2008 operating earnings per share to be $0.92 per share, a 14 percent increase over the 2007 first-quarter level.  We believe Aetna is very well positioned to continue to sustain long-term operating earnings per-share growth of 15 percent,” Zubretsky said. (2)

Health Care business results
Health Care, which provides a full range of insured and self-insured medical, dental, pharmacy and behavioral health products and services, reported:
 
·
Operating earnings of $439.6 million for the fourth quarter of 2007, compared with $412.2 million for the fourth quarter of 2006. The increase in operating earnings reflects a 15 percent increase in revenue primarily from membership growth, premium and fee rate increases and acquisitions, as well as solid underwriting results, continued general and administrative expense efficiencies and higher net investment income.
 
·
Net income of $439.2 million for the fourth quarter of 2007, compared with $418.7 million for the fourth quarter of 2006.
 
·
A Commercial Medical Benefit Ratio (“MBR”) of 79.2 percent for the fourth quarter of 2007, compared to 78.3 percent for the fourth quarter of 2006.  The Commercial MBR for the fourth quarter of 2006 included approximately $42 million pretax of favorable development of prior-period health care cost estimates.
 
·
A Medicare MBR of 86.5 percent for the fourth quarter of 2007, compared to 83.8 percent for the fourth quarter of 2006.
 
·
A total MBR of 80.3 percent for the fourth quarter of 2007, compared to 78.8 percent for the fourth quarter of 2006. Total MBR combines the benefit ratios of the Commercial, Medicare and Medicaid products.
 
·
Fourth quarter medical membership increased organically by 168,000. Including Goodhealth Worldwide’s 58,000 members, total medical membership at December 31, 2007 was 16.853 million members.  Fourth quarter pharmacy membership increased by 63,000 to 10.732 million and dental membership increased by 142,000 to 13.406 million.


Aetna/4
 
·  Total revenues for the fourth quarter of 2007 increased by 15 percent to $6.4 billion from $5.6 billion for the fourth quarter of 2006.
 
Full-year 2007 operating earnings for Health Care were $1.8 billion, compared with 2006 operating earnings of $1.6 billion.  Full-year 2007 operating earnings were higher primarily due to total revenue growth, primarily from higher membership levels and premium and fee rate increases, as well as solid underwriting results, continued general and administrative efficiencies and higher net investment income.  Full-year net income for 2007 was $1.7 billion, compared with $1.5 billion for 2006.  Full-year 2007 Commercial MBR was 79.5 percent, compared to 79.3 percent for 2006.  Full-year 2007 organic medical membership growth was 730,000, an increase of 5 percent over 2006.

Group Insurance business results
Group Insurance, which includes group life, disability and long-term care products, reported:
 
·
Operating earnings of $37.0 million for the fourth quarter of 2007, compared with $29.9 million for the fourth quarter of 2006, reflecting a lower group benefit ratio partially offset by higher general and administrative expenses.
 
·
Net income of $32.4 million for the fourth quarter of 2007, compared with $34.6 million for the fourth quarter of 2006.
 
·
Total revenues of $536.7 million for the fourth quarter of 2007, compared with $537.0 million for the fourth quarter of 2006.

For full-year 2007, Group Insurance reported operating earnings of $145.5 million, compared with $132.7 million for 2006.  The increase was primarily due to a lower group benefit ratio as well as higher net investment income.  Full-year net income for 2007 was $120.4 million, compared with $133.9 million for 2006.


Large Case Pensions business results
Large Case Pensions, which manages a variety of discontinued and other retirement and savings products, primarily qualified pension plans, reported:
 


Aetna/5
 
 
·
Operating earnings of $11.4 million for the fourth quarter of 2007, compared with $8.9 million for the fourth quarter of 2006.
 
·
Net income of $10.3 million for the fourth quarter of 2007, compared with $7.6 million for the fourth quarter of 2006.
 
For full-year 2007, Large Case Pensions reported operating earnings of $38.1 million, compared with $38.9 million for 2006.  Full-year net income for 2007 was $79.0 million compared with $122.6 million for 2006.  Net income for full-year 2007 and 2006 includes $41.8 million and $75.0 million, respectively, of after-tax benefits related to the reduction of reserves for discontinued products.
 
Total company results
·
Total Revenues.  Revenues increased 12 percent to $7.1 billion for the fourth quarter of 2007, compared with $6.4 billion for the fourth quarter of 2006. The growth in fourth-quarter revenue reflects a higher level of membership, premium and fee rate increases and revenue from the recent acquisition of Schaller Anderson which together resulted in an increase of 14 percent in premiums and 11 percent in fees and other revenue.  For full-year 2007, total revenues were $27.6 billion, compared with $25.1 billion for 2006, a 10 percent increase.
·
Total Operating Expenses.  Operating expenses were $1.4 billion for the fourth quarter of 2007, $127.1 million higher than the fourth quarter of 2006.  Operating expenses as a percentage of revenue(3) improved to 19.0 percent for the fourth quarter of 2007 from 19.4 percent for the fourth quarter of 2006, reflecting continued expense efficiencies, offset by investments in growth initiatives.  Including net realized capital gains (losses), these percentages were 19.0 percent for the fourth quarter of 2007 and 19.3 percent for the fourth quarter of 2006.  For full-year 2007, operating expenses as a percentage of revenue (3) improved to 18.2 percent from 18.8 percent for 2006.  Including net realized capital gains (losses) and other items, these percentages were 18.3 percent for full-year 2007 and 19.2 percent for full-year 2006.
·
Corporate Interest Expense was $33.5 million after tax for the fourth quarter of 2007, compared with $26.8 million for the fourth quarter of 2006.  Corporate interest expense was $117.4 million after tax for full-year 2007, compared with $96.4 million for 2006.  The increase for fourth-quarter and full-year 2007 was due to higher average debt levels in 2007.


Aetna/6
 
·  Net Income. Aetna reported net income of $448.4 million for the fourth quarter of 2007, compared with $434.1 million for the fourth quarter of 2006.  For full-year 2007, Aetna reported net income of $1.8 billion, compared with $1.7 billion for 2006.
·
Operating Margin was 10.8 percent for the fourth quarter of 2007, compared with 11.3 percent for the fourth quarter of 2006, pre-tax.(4) The after-tax operating margin, which represents income from continuing operations divided by total revenue, was 6.3 percent for the fourth quarter of 2007, compared with 6.8 percent for the fourth quarter of 2006.  For full-year 2007 the pre-tax operating margin (4) improved to 11.1 percent from 11.0 percent for 2006.  The after-tax operating margin was 6.6 percent for full-year 2007 compared to 6.7 percent for 2006.
·
Share repurchases.  Aetna repurchased 6.1 million shares at a cost of $348.1 million in the fourth quarter of 2007, bringing full year total shares repurchased to 33.2 million, at a cost of $1.7 billion.
 
A live audio webcast of the fourth-quarter results conference call will begin at 8:30 a.m. ET today.  The public may access the conference call through a live audio webcast available on Aetna’s Investor Information link on the Internet at www.aetna.com.  Financial, statistical and other information, including GAAP reconciliations, related to the conference call also will be available on Aetna’s Investor Information web site.

The conference call also can be accessed by dialing 866-454-4207, or 913-312-0824 for international callers.  The Company suggests participants dial in approximately 10 minutes before the call.  Individuals who dial in will be asked to identify themselves and their affiliations.

A replay of the call may be accessed through Aetna’s Investor Information link on the Internet at www.aetna.com or by dialing 888-203-1112, or 719-457-0820 for international callers. The replay access code is 8490606. Telephone replays will be available from 11:30 a.m. ET on February 7 until midnight ET on February 20, 2008.

Aetna is one of the nation’s leading diversified health care benefits companies, serving approximately 36.7 million people with information and resources to help them make better informed decisions about their health care. Aetna offers a broad range of traditional and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, and medical management capabilities and health care management services for Medicaid plans. Our customers include employer groups, individuals, college students, part-time and hourly workers, health plans, governmental units, government-sponsored plans, labor groups and expatriates. www.aetna.com



Aetna/7

Consolidated Statements of Income
 
                           
                           
                           
     
For the Three Months
   
For the Twelve Months
 
     
Ended December 31,
   
Ended December 31,
 
(Millions)
   
2007
   
2006
   
2007
   
2006
 
                           
Revenue:
                         
Health care premiums
    $ 5,583.4     $ 4,845.2     $ 21,500.1     $ 19,153.5  
Other premiums
      486.2       473.5       1,979.3       1,956.0  
Fees and other revenue
      799.1       717.9       3,044.0       2,839.3  
Net investment income
      285.0       312.6       1,149.9       1,164.7  
Net realized capital (losses) gains
    (9.3 )     10.3       (73.7 )     32.2  
 Total revenue
 
    7,144.4       6,359.5       27,599.6       25,145.7  
                                   
Benefits and expenses:
                                 
Health care costs
      4,480.7       3,819.1       17,294.8       15,301.0  
Current and future benefits
    543.4       585.4       2,248.1       2,319.0  
Operating expenses:
                                 
Selling expenses
      267.2       237.4       1,060.9       952.7  
General and administrative expenses (5)
    1,088.9       991.6       3,985.5       3,867.9  
     Total operating expenses
    1,356.1       1,229.0       5,046.4       4,820.6  
Interest expense
      51.5       41.1       180.6       148.3  
Amortization of other acquired intangible
                               
assets
      28.1       21.9       97.6       85.6  
Reduction of reserve for anticipated future
                               
losses on discontinued products
    -       -       (64.3 )     (115.4 )
  Total benefits and expenses
    6,459.8       5,696.5       24,803.2       22,559.1  
                                   
Income from continuing operations before
                               
income taxes
      684.6       663.0       2,796.4       2,586.6  
Income taxes
      236.2       228.9       965.4       901.0  
Income from continuing operations
    448.4       434.1       1,831.0       1,685.6  
Income from discontinued operations,
                               
 net of tax
      -       -       -       16.1  
Net income
    $ 448.4     $ 434.1     $ 1,831.0     $ 1,701.7  
                                   
                                   
Shareholders' equity at December 31, 2007 and 2006
                  $ 10,038.4     $ 9,145.1  



Aetna/8

Summary of Results
 
                         
                         
   
For the Three Months
   
For the Twelve Months
 
   
Ended December 31,
   
Ended December 31,
 
(Millions)
 
2007
   
2006
   
2007
   
2006
 
                         
Operating earnings
  $ 454.5     $ 424.2     $ 1,837.1     $ 1,647.9  
      Debt refinancing charge
    -       -       -       (8.1 )
      Physician class action settlement insurance-
                               
  related charge
    -       -       -       (47.1 )
      Reduction of reserve for anticipated future
                               
  losses on discontinued products
    -       -       41.8       75.0  
      Acquisition-related software charge
    -       -       -       (6.2 )
      Net realized capital (losses) gains
    (6.1 )     9.9       (47.9 )     24.1  
Income from continuing operations  (GAAP
                               
      measure)
    448.4       434.1       1,831.0       1,685.6  
   Income from discontinued operations
    -       -       -       16.1  
Net income (GAAP measure)
  $ 448.4     $ 434.1     $ 1,831.0     $ 1,701.7  
                                 
Weighted average common shares - basic
    500.2       520.5       509.2       546.2  
                                 
Weighted average common shares - diluted
    516.3       541.8       527.0       569.1  
                                 
                                 
                                 
                                 
Summary of Results Per Common Share
 
                                 
                                 
Operating earnings
  $ .88     $ .78     $ 3.49     $ 2.90  
      Debt refinancing charge
    -       -       -       (.01 )
      Physician class action settlement insurance-
                               
  related charge
    -       -       -       (.08 )
      Reduction of reserve for anticipated future
                               
  losses on discontinued products
    -       -       .08       .13  
      Acquisition-related software charge
    -       -       -       (.01 )
      Net realized capital (losses) gains
    (.01 )     .02       (.10 )     .03  
Income from continuing operations  (GAAP
                               
         measure)
    .87       .80       3.47       2.96  
  Income from discontinued operations
    -       -       -       .03  
Net income (GAAP measure)
  $ .87     $ .80     $ 3.47     $ 2.99  
                                 
Shareholders' equity (6) at December 31, 2007 and 2006
                  $ 20.23     $ 17.72  



Aetna/9

Segment Information (7)
 
                           
                           
     
For the Three Months
   
For the Twelve Months
 
     
Ended December 31,
   
Ended December 31,
 
(Millions)
 
2007
   
2006
   
2007
   
2006
 
Health Care:
                       
Premiums:
                       
Commercial
  $ 4,825.7     $ 4,383.9     $ 18,656.8     $ 17,356.5  
Medicare
    634.3       453.1       2,598.3       1,787.7  
Medicaid
    123.4       8.2       245.0       9.3  
Total premiums
  $ 5,583.4     $ 4,845.2     $ 21,500.1     $ 19,153.5  
                                   
Total revenue
  $ 6,446.0     $ 5,627.9     $ 24,768.6     $ 22,240.5  
                                   
Selling expenses
  $ 244.0     $ 216.2     $ 966.6     $ 867.4  
General and administrative expenses
    1,014.9       923.7       3,708.3       3,618.6  
Total operating expenses
  $ 1,258.9     $ 1,139.9     $ 4,674.9     $ 4,486.0  
                                   
Operating earnings
  $ 439.6     $ 412.2     $ 1,770.9     $ 1,572.7  
 
Debt refinancing charge
    -       -       -       (8.1 )
 
Physician class action settlement
                               
 
    insurance-related charge
    -       -       -       (47.1 )
 
Net realized capital (losses) gains
    (.4 )     6.5       (21.9 )     8.0  
Net income (GAAP measure)
  $ 439.2     $ 418.7     $ 1,749.0     $ 1,525.5  
                                   
Medical Benefit Ratios:
                               
Commercial
    79.2 %     78.3 %     79.5 %     79.3 %
Medicare
    86.5 %     83.8 %     86.8 %     85.2 %
Medicaid
    89.4 %     *       88.4 %     *  
Total
      80.3 %     78.8 %     80.4 %     79.9 %
* Not meaningful
                               
                                   
Group Insurance:
                               
Total revenue
  $ 536.7     $ 537.0     $ 2,139.5     $ 2,152.1  
                                   
Selling expenses
  $ 23.2     $ 21.2     $ 94.3     $ 85.3  
General and administrative expenses
    70.1       63.5       261.9       232.3  
Total operating expenses
  $ 93.3     $ 84.7     $ 356.2     $ 317.6  
                                   
Operating earnings
  $ 37.0     $ 29.9     $ 145.5     $ 132.7  
       Acquisition-related software charge
    -       -       -       (6.2 )
       Net realized capital (losses) gains
    (4.6 )     4.7       (25.1 )     7.4  
Net income (GAAP measure)
  $ 32.4     $ 34.6     $ 120.4     $ 133.9  

 
 

Aetna/10

Segment Information continued (7)
 
                         
                         
                         
   
For the Three Months
   
For the Twelve Months
 
   
Ended December 31,
   
Ended December 31,
 
(Millions)
 
2007
   
2006
   
2007
   
2006
 
Large Case Pensions:
                       
Total revenue
  $ 161.7     $ 194.6     $ 691.5     $ 753.1  
                                 
Operating earnings
  $ 11.4     $ 8.9     $ 38.1     $ 38.9  
         Reduction of reserve for anticipated future
                               
     losses on discontinued products
    -       -       41.8       75.0  
         Net realized capital (losses) gains
    (1.1 )     (1.3 )     (.9 )     8.7  
Net income (GAAP measure)
  $ 10.3     $ 7.6     $ 79.0     $ 122.6  
                                 
                                 
                                 
Total Company:
                               
Revenue, excluding net realized capital (losses) gains (A)
  $ 7,153.7     $ 6,349.2     $ 27,673.3     $ 25,113.5  
         Net realized capital (losses) gains
    (9.3 )     10.3       (73.7 )     32.2  
Total revenue (B) (GAAP measure)
  $ 7,144.4     $ 6,359.5     $ 27,599.6     $ 25,145.7  
                                 
Selling expenses
  $ 267.2     $ 237.4     $ 1,060.9     $ 952.7  
General and administrative expenses
    1,088.9       991.6       3,985.5       3,774.8  
Operating expenses, excluding other items (C)
    1,356.1       1,229.0       5,046.4       4,727.5  
  Debt refinancing charge
    -       -       -       12.4  
  Physician class action settlement
                               
     insurance-related charge
    -       -       -       72.4  
  Acquisition-related software charge
    -       -       -       8.3  
Total operating expenses (D) (GAAP measure)
  $ 1,356.1     $ 1,229.0     $ 5,046.4     $ 4,820.6  
                                 
Operating Expenses Percentages:
                       
Operating expenses as a % of revenue (C)/(A)
    19.0 %     19.4 %     18.2 %     18.8 %
Total operating expenses as a % of total revenue (D)/(B)
                               
         (GAAP measure)
    19.0 %     19.3 %     18.3 %     19.2 %


Aetna/11

                       
Membership
                       
                       
                       
   
December 31,
     
December 31,
   
September 30,
   
(Thousands)
 
2007
     
2006
   
2007
   
Medical Membership:
                     
Commercial
    15,871         15,141       15,660    
Medicare Advantage
    193         123       191    
Medicare Health Support Program
    14         17       15    
Medicaid
    775         152       747    
     Total Medical Membership
    16,853  (8)       15,433       16,613  (8)  
                             
Consumer-Directed Health Plans (9)
    994         676       980    
                             
Dental Membership:
                           
Commercial
    12,468         12,262       12,426    
Network Access (10)
    938         1,210       838    
     Total Dental Membership
    13,406         13,472       13,264    
                             
Pharmacy Membership:
                           
Commercial
    9,634         9,161       9,570    
Medicare PDP (stand-alone)
    311         314       309    
Medicare Advantage PDP
    151         115       150    
     Total Pharmacy Benefit Management Services
    10,096         9,590       10,029    
Mail Order (11)
    636         625       640    
     Total Pharmacy Membership
    10,732         10,215       10,669    

 


Aetna/12

                         
Operating Margins
 
                         
                         
   
For the Three Months
   
For the Twelve Months
 
   
Ended December 31,
   
Ended December 31,
 
(Milllions)
 
2007
   
2006
   
2007
   
2006
 
Reconciliation to Income from continuing
                       
  operations before income taxes:
                       
Operating earnings before income taxes, excluding
                       
      interest expense and amortization of other acquired
                       
      intangible assets (A)
  $ 773.5     $ 715.7     $ 3,084.0     $ 2,766.0  
Interest expense
    (51.5 )     (41.1 )     (180.6 )     (148.3 )
Amortization of other acquired intangible assets
    (28.1 )     (21.9 )     (97.6 )     (85.6 )
Debt refinancing charge
    -       -       -       (12.4 )
Physician class action settlement insurance-related
                               
  charge
    -       -       -       (72.4 )
Reduction of reserve for anticipated future losses
                               
  on discontinued products
    -       -       64.3       115.4  
Acquisition-related software charge
    -       -       -       (8.3 )
Net realized capital (losses) gains
    (9.3 )     10.3       (73.7 )     32.2  
Income from continuing operations before income
                               
     taxes (B) (GAAP measure)
  $ 684.6     $ 663.0     $ 2,796.4     $ 2,586.6  
                                 
Reconciliation to Income from continuing
                               
 operations:
                               
Operating earnings, excluding interest expense and
                               
    amortization of other acquired intangible assets (C)
  $ 506.3     $ 465.3     $ 2,017.9     $ 1,800.0  
Interest expense, net of tax
    (33.5 )     (26.8 )     (117.4 )     (96.4 )
Amortization of other acquired intangible assets,
                               
  net of tax
    (18.3 )     (14.3 )     (63.4 )     (55.7 )
Debt refinancing charge, net of tax
    -       -       -       (8.1 )
Physician class action settlement insurance-related
                               
  charge, net of tax
    -       -       -       (47.1 )
Reduction of reserve for anticipated future losses
                               
  on discontinued products, net of tax
    -       -       41.8       75.0  
Acquisition-related software charge, net of tax
    -       -       -       (6.2 )
Net realized capital (losses) gains, net of tax
    (6.1 )     9.9       (47.9 )     24.1  
Income from continuing operations (D) (GAAP
                               
      measure)
  $ 448.4     $ 434.1     $ 1,831.0     $ 1,685.6  
                                 
Reconciliation of Revenue:
                               
Revenue, excluding net realized capital (losses)
                               
    gains (E)
  $ 7,153.7     $ 6,349.2     $ 27,673.3     $ 25,113.5  
Net realized capital (losses) gains
    (9.3 )     10.3       (73.7 )     32.2  
Total revenue (F) (GAAP measure)
  $ 7,144.4     $ 6,359.5     $ 27,599.6     $ 25,145.7  
                                 
Operating Margins:
                               
Pretax operating margin (A)/(E)
    10.8 %     11.3 %     11.1 %     11.0 %
Pretax operating margin (B)/(F) (GAAP measure)
    9.6 %     10.4 %     10.1 %     10.3 %
                                 
After-tax operating margin (C)/(E)
    7.1 %     7.3 %     7.3 %     7.2 %
After-tax operating margin (D)/(F) (GAAP measure)
    6.3 %     6.8 %     6.6 %     6.7 %


Aetna/13
 
(1) Operating earnings exclude net realized capital gains and losses and other items, if any, from income from continuing operations as discussed below. Although the excluded items may recur, management believes that operating earnings and operating earnings per share provide a more useful comparison of the Company’s underlying business performance from period to period.  Management uses operating earnings to assess business performance and to make decisions regarding the Company’s operations and allocation of resources among the Company’s businesses.  Operating earnings is also the measure reported to the Chief Executive Officer for these purposes.  Each of the excluded items is discussed below:
·
Net realized capital gains and losses arise from various types of transactions, primarily in the course of managing a portfolio of assets that support the payment of liabilities. However, these transactions do not directly relate to the underwriting or servicing of products for customers and are not directly related to the core performance of the Company’s business operations.
·
Release of reserves for anticipated future losses on discontinued products of $41.8 million and $75.0 million, after tax, are considered other items for the years ended December 31, 2007 and 2006, respectively, as they represent a reduction of reserves previously established for certain products no longer offered by the Company that do not benefit ongoing business operations.
·
A debt refinancing charge of $8.1 million, after tax ($12.4 million pretax), represents the net charge from the write-off of debt issuance costs and the recognition of deferred gains on terminated interest rate swaps in connection with the redemption of the Company’s 8.5 percent senior notes due 2041.  This is an other item for the year ended December 31, 2006, as it does not reflect underlying 2006 business performance.
·
The write-off of a $47.1 million, after tax ($72.4 million pretax), insurance recoverable related to a prior-year physician class action settlement as a result of a trial court summary judgment ruling. This is an other item for the year ended December 31, 2006, as it does not reflect underlying 2006 business performance.
·
As a result of the acquisition of Broadspire’s disability business in 2006, the Company impaired approximately $6.2 million, after tax ($8.3 million pretax), of the Company’s previously capitalized software, due to the acquisition of a more multifunctional system.  This is an other item for the year ended December 31, 2006 as it does not reflect underlying 2006 business performance.

For a reconciliation of these items to financial measures calculated under U.S. generally accepted accounting principles (GAAP), refer to the tables on pages 8 through 10 and page 12 of this press release.

(2) Projected operating earnings per share exclude any future net realized capital gains or losses and other items, if any, from income from continuing operations. The Company is not able to project the amount of future net realized capital gains or losses and therefore cannot reconcile projected operating earnings to projected income from continuing operations, or to a projected change in income from continuing operations, in any period. Projected operating earnings per share for the full-year 2008 assumes approximately 505 million weighted-average diluted shares.

(3) Operating expenses as a percentage of revenue excludes net realized capital gains and losses from total revenue. Net realized capital gains and losses do not directly relate to underwriting or servicing of products for customers and are not directly related to the core performance of the Company’s business operations. Operating expenses exclude the other items described in footnote (1).

(4)  In order to provide useful information regarding profitability of the Company on a basis comparable to others in the industry, without regard to financing decisions, income taxes or amortization of other acquired intangible assets (each of which may vary for reasons not directly related to the performance of the underlying business), the Company’s pretax operating margin excludes interest expense, income taxes and amortization of other acquired intangible assets. Management also uses pretax operating margin to assess the Company’s performance, including performance versus competitors. Operating earnings used in the pretax margin calculation also exclude the other items described in footnote (1).

 
(5) General and administrative expenses for the year ended December 31, 2006 include the debt refinancing charge, insurance-related charge and the acquisition-related software charge discussed in footnote (1) above.
 

(6) Actual common shares outstanding were 496.3 million and 516.0 million at December 31, 2007 and 2006, respectively.

(7) Revenue and operating expense information is presented before income taxes.  Operating earnings information is presented net of income taxes.

(8) Includes approximately 600,000 and 575,000 Medicaid (112,000 and 111,000 Insured and 488,000 and 464,000 ASC) and 44,000 and 43,000 Commercial ASC members at December 31, 2007 and September 30, 2007, respectively, from the Schaller Anderson acquisition and approximately 58,000 Commercial members (1,000 Insured and 57,000 ASC) at December 31, 2007 from the Goodhealth Worldwide acquisition.

(9) Represents members in consumer-directed health plans included in the Company's Commercial medical membership.

(10) Represents members in products that allow these members access to the Company's dental provider network for a nominal fee.

(11) Represents members who purchased medications through Aetna Rx Home Delivery®, our mail order pharmacy, during the fourth quarter of the applicable year.

 

Aetna/14
 
ADDITIONAL INFORMATION; CAUTIONARY STATEMENT -- Certain information in this press release is forward looking, including our projections as to operating earnings and weighted-average diluted shares. Forward-looking information is based on management's estimates, assumptions and projections, and is subject to significant uncertainties and other factors, many of which are beyond Aetna's control. Important risk factors could cause actual future results and other future events to differ materially from those currently estimated by management, including failure to achieve desired rate increases and/or profitable membership growth due to significant competition, reputational issues or other factors in key geographic markets where membership is concentrated; unanticipated increases in medical costs (including increased medical utilization, increased pharmacy costs, increases resulting from unfavorable changes in contracting or re-contracting with providers, changes in membership mix to lower-premium or higher-cost products or membership-adverse selection; as well as changes in medical cost estimates due to the necessary extensive judgment that is used in the medical cost estimation process, the considerable variability inherent in such estimates, and the sensitivity of such estimates to changes in medical claims payment patterns and changes in medical cost trends); and the ability to reduce administrative expenses while maintaining targeted levels of service and operating performance. Other important risk factors include, but are not limited to:  the ability to improve relations with providers while taking actions to reduce medical costs; the ability to successfully implement multiple strategic and operational initiatives simultaneously; reduced levels of investment income from low interest rates; adverse government regulation (including legislative proposals eliminating or reducing ERISA pre-emption of state laws that would increase potential litigation exposure, legislative proposals that would limit our ability to price for the risk we assume and/or reflect reasonable costs or profits in our pricing, and other proposals, such as patients' rights legislation, that would increase potential litigation exposure or mandate coverage of certain health benefits); adverse pricing actions by government payors; changes in size, product mix or medical cost experience of membership in key markets; our ability to integrate, simplify, and enhance our existing information technology systems and platforms to keep pace with changing customer and regulatory needs; the outcome of various litigation and regulatory matters, including litigation and ongoing reviews of business practices by various regulatory authorities; and increases in medical costs or Group Insurance claims resulting from any acts of terrorism, epidemics or other extreme events. For more discussion of important risk factors that may materially affect Aetna, please see the risk factors contained in Aetna's 2006 Annual Report on Form 10-K, on file with the Securities and Exchange Commission (“SEC”), and Aetna’s 2007 Annual Report on Form 10-K when filed with the SEC.  You also should read Aetna's 2006 Annual Report on Form 10-K and September 30, 2007 Quarterly Report on Form 10-Q on file with the SEC, and Aetna’s 2007 Annual Report on Form 10-K when filed with the SEC for a discussion of Aetna's historical results of operations and financial condition.
 


GRAPHIC 3 aetnalogo.jpg AETNA CORPORATE LOGO begin 644 aetnalogo.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_X0!P17AI9@``24DJ``@````$`!H!!0`! M````/@```!L!!0`!````1@```"@!`P`!`````@#`P#$!`@`9````3@`````` M``!@`````0```&`````!````141'05)I>F5R(%-O9G1W87)E(%-U:71E`![_ MVP!#``(!`0$!`0(!`0$"`@("`@0#`@("`@4$!`,$!@4&!@8%!@8&!PD(!@<) M!P8&"`L("0H*"@H*!@@+#`L*#`D*"@K_VP!#`0("`@("`@4#`P4*!P8'"@H* M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H* M"@K_P``1"``V`)X#`2(``A$!`Q$!_\0`'P```04!`0$!`0$```````````$" M`P0%!@<("0H+_\0`M1```@$#`P($`P4%!`0```%]`0(#``01!1(A,4$&$U%A M!R)Q%#*!D:$((T*QP152T?`D,V)R@@D*%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9 MFJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?H MZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$!`0$!`0````````$"`P0%!@<("0H+ M_\0`M1$``@$"!`0#!`<%!`0``0)W``$"`Q$$!2$Q!A)!40=A<1,B,H$(%$*1 MH;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U15 M5E=865IC9&5F9VAI:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::G MJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W M^/GZ_]H`#`,!``(1`Q$`/P#]U[K7[OQ+I=K?_#S4;"^M;R-F34H+I980HP`5 M*9#YYZ9'%5[;X:Z;)NN==N);Z=^6DDD*@'V`/`_&O'_BE_P3K^&-Q:7'BS]D M[7+OX'>.1F6T\2_#NVCM;2YFZC^T=,`%IJ49.-PFC,F!\LB'FO%_V6/^"L/C M#PS\7O&7[$W_``4>\(Z?X3^+G@30[K6+;5="8C2?&6E6\#W#7ED)""DAAC:0 MQ$X(23[AC>-/%QG`V69]B)8JNG6Y;-0EJHK2\E'9^NZ".85<,E#X;]5U\F^G MH?7T?A/QU/$NGOKD-K:Q86-8068*.`"<`]/>H[OP'J=G`]S-X[GB6-"TDDCD M*H`R226X&*^7/A)_P64^$?B3X<>+/&_C*&+4[C2_$5MI7A6/P-#)>6OBB\N8 M$D&FZ;,Y!O[BWD;RIYD5(09(B#\^T>P?#3X*_$CXX(OQ*_;*L8GDFD2;2/AI M#.LFD:,FU647"J2NHW*MG,LN8U*J8HHSDGQZGA7DE/WL9[1VT3M>Y MOK/3$1]0NXH%DE6)'FD"AG8X51GJ22`!U)-6<8'3%?DI_P`'17[%N&E3E#+L(VTVV MG)N32W>KN[(,;C.2#JS2TMLDO(_6R@``8`KAOV#9`=- M\7>';35;5-^XPB:)7,3?[2,2C#LRD5W`!R:VJ4Y4JCA)6:=FO-%1DIQ36S%H MJ.ZBEGM9(;>Y:&1XRJ3(H)C)'#`$$$CKR,4Z)72-4DE+L!@N0`3[G'%(H=17 M)?%?XS^`_@O::%=>/-1DMQXD\46'A_2%BB+M-?WDOEPI@=!G))[*I/:NM!R, MTG%V3:T>PKINP4444QA1110`4444`.C[TZFQ]Z=0!"0.I/UK\OO^"^/P.UZR M_:7_`&=/VUO#.J0^';'X<:CJ5QXU\3PP[KR6WADM+BPL(%*E)99IOM,2HYVA M9Y78-&DFW]0AGH1VK\O_`/@Y(\0QGPQ\*O`^VYFDN=5O[L6T.J1HK;$@C&ZW MVEW8^8P60$*F7&&+C'T/"M*6(SVC33M??TMK^!\YQ7CY9;D=7$15Y)*WJVDO MN-?_`()5>&H?VT_VE?%'[:GQ]\166J>(_"9BL_"7@_2X7?3/"L$XD*+'($\A MY@@;Y(V9D+L\F)'`3]*,*G"GIUQ7Y-_\$%OB;XV\+?M5_$?]G/QX(=$EM]$' MD^%(8<16EQ97(AE6)LM\P$S%SN9I3\[,Y7=7ZR8[J!S6O%]!X?.I4X_`E'E2 MV2LGIY7N<'`U:.)R.-7[;;YF]V[];Z[6'$X%?AY_P7,_9AOOVLOV=/B7_P`% M+M*MI;F7P?\`%4>&]!=264^%=/)TJ=D_O!M9-U,&''EMGIS7ZT_MR?'\?LM_ MLD>/?CO#-"M[H7AZ8Z*MPP"2ZE+B"RC8G@![F6%#_O5\\:+\;_\`@F9#^PE# M^PUXA_:I\*7>BS?#P^&-3O/M+,]P\EJ8IKOE;=UWG/!KGR'$XG+<5# M%THM^\D[*^FCDOFK'T>.A&O3=*32T;U[]#P__@U8_:P/Q1_8]\1?LOZ]J2R: ME\,]>,VF1R/S_95^7F0#/)V7*W6<<`21CC(S^G7C;QQX/^&WA+4?B!X_\2V. MC:)H]G)=ZIJNI7*PP6L"`L\CNQ`50!G)K^:3_@A5^T5<_L3_`/!5?0?!OB+7 MH3HOBR^N?!.O7$$I,$K3RA;692<`K]KBM\.<81V]37VG_P`'9?[8'BK0-*\` M_L5>$-8EM=/UVUD\2^+HHI"IO(8YC#90MCK&)8[B0J>"\<1ZI7T.>&+Q++Q+\/\`2]%*^)-+NFE\LP3V,SH492') M;=L(BDVLVP@>=_L6?\%"_P#@G[\,?V/_`(6?#F?]I'PKILFA_#S1K&>P:X96 M@ECLH4=6`7[P8')[G)K\EO!O[5OB']GC_@X`U[]H;X"F^OO`7C'XHM9:W"@X.FG*+=_>L]G?JUM: MQT3QD:9/)!=>+/"5M86FC3 M21L5D2UNM0NH!?E6!4M;+)&2"`Y(Q7X:^(?A7HOQO_X.)O$7PC\2:I?VFE^( M/C[JMEJDFF7303R6KW,WG0K(I#()(]\9(((5SCFOZ4_#GAKP]X-\.6/A'PKH MUKINEZ9:1VNGZ=90+%#;01J%2.-%`"JJ@``<`"HSO+N>"/A=\:^%V<>( MO`/C'3UL]5L@DGE2/L5W21%D^1BCDHQ4.$+*#VG[67[<_P"S_P#L;6FBV_Q6 MUV_N]?\`%-Y]C\(>"O#>FO?ZSKUQD#RK6UC^9N64%V*H"R@L"P!_#O\`9-\3 MZOX(_P"#H/67\-W;6RZA\QQG"S03M?AT8=",D-S_$JGJ!7UE_P5$_X M)G_\%._C3_P5W\%_M2$Z?.KOK_+>W?J33QM>5"3C'F:ERZ+IW ML?:7C[_@HC\3?@WX$O/C)\:/^"=_Q>T'P3IMJ;O5=;BO?#]_'-1T#2+J[T:_B$MO) M*LUPFXQME5UL:XV]DXW2O:2;L][V?G?Y&M7$5*6 M(A2O?G3UZIKT/UX_9-_:#\4_&_1=5MO&VBVEKJFDS_O9;&WE@CDC-S=6ZAH) MF:2WEWVDC>6Y+>5)`Y"-(8H_8SD?=%87@[P'X/\`A]I\NE>"O#=MIT,]R;BY M%O'AIYBH4RR,?FD@K\[_`-J;P-X9_:S_`."UOPW^#7B=6NM'^'7@H:]JELF,-\K+3T3;/$SO! MU,PC1HJ-XN:'_`!`& M8&-+];1+:W"X`V^83;<$G+1.>]?H*#QG-?/_`/P41_9<\8_M1?!O1[/X6W%C M;^,/"7C'3/$/ABYU&8Q1+/;S`.&=58J#$\A&`P>/\`4O'^A^"+S5/A MMX1L=?U^&%?[/TC4]9.GP7+;@"'N!#,8@%+'/EMD@#`SD&.Q2QN'H-N\XIQ= MWT3NOE9V^097@I8#&XB"C:G)J47TNU9KUNOQ/%/VH9!\7/VK_@M^S/;GS;/3 M]3N_B)XLC5ONVNDJD.GQOV&_4KRUF7N?L#XZ$U]$^6F-H05\3?#'PO\`\%3_ M``M^U;\0/VE?'/[+GPFU=?%NB:3HOA_3+;XO7<$N@Z=8M=2>3YK:0XN#+-=R M2NP2+D*,$*,?:EL]Y):QF[C6.9D!D1'W!6QR`<#(![X% MG?!GP3\!_AQH5MX7\:2:EH?C/4_B5<2W5S9B.:'RS:KIBB`S*\4CKYLFUHE7 M+?>KR3]EG_@BU^V3I?[%^L_\$Z_VQ/AYX"\1^"-7\6KK?A[QCH?CZ>/4_!MT M\:QR7%M!)I[+<@8+>49(@_FS*6_>;E_1<#GF#AEV$KUIKVU&\6KJ[@U:ZUW6 MCMN[,\&MA*LL14A"+Y9:IV=KK7_,_2S]BMHIOV.?A1)#AU;X;:$593P1_9\' M-;'Q]^-OA#]G/X5ZI\7O&NGWMU9Z<]O#%I^E1))=WMS<3QV]O;0([HKRRS2Q MQHI906<9(ZU\T?LEV_\`P4:_8K^#>B_LM?$3]F*R^+>F^"].CTSPKX]\$^-+ M"P:^TZ$;+:*[L]2>%H9HX@B$QO*I"CDD$MWWA/X.?M&?M)?%7P_\8OVO/#NC M^$O#G@[4!J?@[X5:+JW]I.VJ*K)'J.J7@1(Y9(0S&&VA5HXW82&21TCV?G]: MC%8B4W).-V]&FWVT3NOFCVX3_=J*BU*W5;?,_(;]K7YO^#K'3/E_YJKX,Y_[ MA>EU_003A=WMQ7Y6?\%*?^"/G[4^N_\`!2OPQ_P5"_8ST[1?%NHV?B#1-5\1 M>!=7UE-.FFN-.$$2F&>0>5Y,+^1#;@7U]9VTL5K8P132S+"%F:>>.'>(U3GV MLZJX?,,/A)49KW*:C)-I--=+-W^>WHCCP49T*E123UDVM':S\S\;/AV`O_!S MS<@_]'#ZIC_O_<5_1X0-IP/X>*_%3PW_`,$6?^"HV@_\%-&_X*,GP?\`"N:9 M_B1<^*6\(_\`"?72KLFF=S:BY_L\\A7V^;Y?4;MG\-?K7?>+OVC(_@E'XIL/ M@CXVQ_P`'/U^S?]'`^)L_]_+ZO<_C M#_P4=_:;_P""J'_!6W2O^"=7PB^,^N_#;X3IXQO](OY/"%\UEJ.M6VG17$UY M/)=)^\7S4M9ECC!"*KH71V!K:^'?_!&+_@J)X#_X*:R?\%'7\&_"JZEF^(FH M^)I?"(\?7:*$NY)F:V%S_9YY59B!)Y?)4'9SBH_B)_P14_X*)?LU?M]:)_P4 M._8E\$^%-5N[GQ'+XAU#P%<>*T4Z/I!SJ17:R7#N"`=S. M3GFOS2_X-#CCXZ?&7_L5=,_]*9:_2_5;?_@H/^V+X+G^#_Q+^!NC?`CPOK5L MUIXRU2+QW%KVMW-G(NV>UTY;:!8+9I$+1_:I9&:-7)2$L`R_%'_!.[_@EM_P M4[_X)0_M8^.I?@7\-?`OQ%\'>,-*.FZ9XFUSQG_9D=DJ3^9;7=S`L,D[,BEA M)!$A#%OEE&`3\_E^*IPR7&86M57M)\K2;33L[O7:_E<[*]-RQ5*I"+Y5>]E^ MFY^PJ$`'-.4$#FN6^#WAKXA>$/AKI'AWXJ?$0^+/$=M:`:SX@.FQ6:WEP26= MD@B&V*,$[47E@BKN9VRQZ@#/.W]:^-:Y966OF>PG=#L#&,4444QA1110`8&< LXHHHH`"`>HHP/2BB@`P/2BBB@`P!T%%%%`!1110`4444`%%%%`!1110!_]D_ ` end GRAPHIC 4 aetnalogo2.jpg CORPORATE LOGO begin 644 aetnalogo2.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_X1:217AI9@``24DJ``@````'`!(!`P`! M`````0`(;1H!!0`!````8@```!L!!0`!````:@```"@!`P`!`````@```#$! M`@`9````<@```#(!`@`4````C````&F'!``!````H````,H````L`0```0`` M`"P!```!````141'05)I>F5R(%-O9G1W87)E(%-U:71E`'`R,#`V.C`T.C(U M(#`Y.C$W.C,P``,``:`#``$```#__P```J`$``$```!)`@```Z`$``$````9 M`0````````8``P$#``$````&```*&@$%``$````8`0``&P$%``$````@`0`` M*`$#``$````"`````0($``$````H`0```@($``$```!B%0```````$@````! M````2`````$```#_V/_@`!!*1DE&``$"``!(`$@``/_M``Q!9&]B95]#30`" M_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)#!$+"@L1%0\,#`\5&!,3 M%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`$-"PL- M#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,#!$,#`P,#`P,#`P,#`P, M#`P,#`P,#`P,#`P,#`P,_\``$0@`30"@`P$B``(1`0,1`?_=``0`"O_$`3\` M``$%`0$!`0$!``````````,``0($!08'"`D*"P$``04!`0$!`0$````````` M`0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!``(1`P0A$C$%05%A$R)Q M@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U%J*R@R9$DU1D1<*C=#87 MTE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]C='5V=W MAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#(3$2!$%187$B$P4R@9$4 MH;%"(\%2T?`S)&+A7U5F9VAI:FML;6YO8G-T=79W>'EZ>W MQ__:``P#`0`"$0,1`#\`]526'U7)RL'ZQ=)N]5PPG8-&>VL7XMMU%=UF[8*ZKW-J^U?1?ZGINLK_1 MH'%($:?-\O\`638^QTDES=_UTQZ+.K-LQR&=,J?9C/+H^TFIWV;(KK]GZ'TL M_9A_X7^<4>J?7"SI5_IY>/C-:ST?5J&8PY7Z7;ZC\?!]+??7CN?^?;1ZNSU& M,1&*9TK=7$.[TR2YO-^M.?CW=4]#I@OQNBD.R[C>&%S/3KR7_9ZO2?ONKJ>] M[ZGV5_0_GO4M]--5UGK=OUL^PLIJ=T\XC+VM]2#Z;[',^W:X_J>K[?3^Q;_^ M$]9+VI5>FW%N%<0_&GI4EEY?6Z\+J]6!E,%6/=C6Y->6Y^A=06G(H]+;^90_ M[1ZF_P#TBS\7ZT]2SVX]>!TL695N*W-NKLR`RNJJTO\`L=9O;3:Y^5E,KW^E MZ-?I?GV(#'(BZT[V%6'I$EB=.^LK.H7=/KKQW5C/JR;'^H8=59B/JQ[\=]8! MW_I;7>_?_@U:Z9U6SJ.-EVUT!EF-D9&,RLOD/-#W4M>7[/T?K;?W'^E_+0,) M#ZXVC'IZYM5FVWTL=S;:;7M997Z2,L M4A>VG8H$@7727*YG6[>G_6G-QZF/S,K)QL5N#@!Y:'OW93K[-SM]6/556&OR M+]JMY?U@ZM7GY.!A],9E6X6/7DWO.1Z;/>+/T%9-#W>JYU/Z#V['_P"%]!'V MI:5U`EOPJL.^DL`?6;(RWXE/1\'[5=E8;.H/]:WT&5TV_P`PQ]C:\G=D6O:] MGIM9_P!<0\;ZY8]CJWY..[%H?BY.0][W@O9=A/\`2ZAA.I8/I4M_3,M]3]+7 M_@T/:GV_'7[%6'HU4HZKTW(R78M&0RR]D@L:>[=+-I^B_P!)W\[L_F_SUDX/ MUL=EMZ?4 M;FNJQ_YN`=[]M;L:CU9/IT^A0][;/L_]-L_3W?S?IH\`C?'Z37I\47=5KW?_ MT/1.O=&KZUTYV$ZUV._>RRG(8`7UO8X/;97/YWYBIYOU2P\H=)9ZKZZND!C! M6`"+:F&E[:+Y_P`'ZF)0];CG-:)<0`.Y5U[9_.K=[V)VY)IEF007 M*?#./Z-?K8A^A9^K_^";/8MO[>T?38YO\`KY[59:0YH<.")4N'G8Y"?;R< M1CJ17RV>+Y9?UD2Q$;BK=H_1[J&X7L_?]K/43/Z!8 MWJN)U/%S'T/HH9B9%>QCVW4L=ZK6>[^8?O+OTC%L)*3CEW_E\JV@\U];L"WJ M]F%TJG'NW.M#[US*V65OJ:7/J:['N&SU:7/=Z-W_`%O](Q;"2/N$``?HWX_,JM_%P'_5 M-M-&`SI>;;A9'3A:VO(<&WE[<@MLR_M#+O;99=S:,ZS"RVLC0LNH?ML9M=[/]&M)<3]?NDV8?I_6KI1^S M=0PW,&18S3U&.(J8ZUO^$V.D3'7]V,ULI& M(O<#4C^#V#K\09+<=UE8R7M+V5$M]0L:8<]K/I[&N=])!ZAU/$Z>UGK$NMM) M%&/6-]MK@)V4U-^E_7_FZ_\`"/7!974K+;\;ZQ59#-V:]N1C8-+#]H<]E;<% M^-F97T_V=C9-5_IX]#?UZRVW_CJ>PZ!TB_&:[J'4G>OU;*'Z:QT'TV_2;BU; M?976S_">E_A/^MI\L$<<1.77]$>F4I_I?XO[RP9N*1A'4C4RWC&/Z/\`A2;V M"_J%S7OSJ:\<.(]*EKM[VMC7U[/YKU-WYM/L9_I;5;25'K?4F]+Z3E=0=$X] M;G,:?SGGVTU_]T M?HLASO\`BLENW^H^I;J\8^J^??T/ZTT.RB6$6NQ,Z3^^[TK?4=_P63LN=_Q: M]G4W,XACD*^4@5^UCPY..))T()!4DDDH&5222Y_J?6G,^MG1NC8]L>IZ]V96 MW]T4V_9F6?UK`^W_`*TG1B9$@=`9?XOJ02!OY?:]`DDDFI4DDDDI22222E)) M))*?_]+U59/UJKQ[?J]G5Y)>*'5^_P!/Z9$M]K)#MKG_`$/4_P`'_.+66)]< MK_1^KN5JYIMV5@L=M/NVNEINKJK):"UE;=M56/B4.$;A*/R M^J'EP=&G\/E.IQG\WIGK^E[@XN)FL+K\YO4^D]';)99<<[*B"/1P]ME;+&_N M6YUF)_F+=7*8S^LYGU@ZGU7IM&+=72YO3:GY-ME3FC'FW+]-M./D->RS,O>S M?O\`^TRK8QJ3^Z.O[Q],6\?S>/\`\8_2?L7U@=D-;%/46"T$"!ZC8JR&C_P* M[_KR]$^JO53U;H&)F/=NN+/3OUD^K7^BMGK,Q[G+`Z&6+337TM>/HY@CID%_X3K_`%H^M>77U;'^K?17-KS\ MBRME^6]H>*19!:VNIWMLM],^L_?[&5?\)9^ALY_U:S\7"MRNG=9ZA]OH8ZRM MUUPMK>YHW^G;BV,^S[+/H?HV,]->>=(RLO+^M].92UC\N_,?:QMKG-87.-C@ MU[V-L>QC6_R%Z98[ZYV5NK=C=,AX+3^L7]Q'_<1-RX_:X(QX1I<^*O4?^]7X MI^YQ$W\QC'Z./]7/K!D?6[%^R69MO2^H8S=UWV05@7U.AK;6?:*[W5>F[VV> MG^__`,)^CY+H&+=?]=V8SRVNQUC:]EN^M=%]5_ MJ']8.B]:Q<^V_%=13N;#B\CZF*1F1BXQ4N,!]%;T?J(QWU'K.6ZQSVN;>68V]H:#NK M:!B^ELL_/WUKSN_ZU]*\C+V/MR[]O\[_`#='J?S7L7.8_P!9>J_5SZUV M=%SLQ_4.FBYE9LR(=:QMS:WU6^M&]WI>JSUOS/\`1^FO1UX[]>?_`!9YO]?' M_P#/5"7+5DE*$@.'A)`KY?)6>1@(R&_$!]'O/KQ]:K?J_AU5X;&OSLO<*B_5 MC&LV^I:YOY[O>QE3/_2?IOATSH7[4Z?5U"SKW4,M^2S?Z]%QQJY_.]+$J8QE M6QWMV6M1_KET3H/4L6K*ZQE'!;B%P9D-,W8S(KJ#:W$&;#Z^;9B-?8ZS.5>G M_'*_7C/$1PT.$?I>+F=.^M?4^D_6A_U=ZK=]OQCW^CCW^B^VKW?3]EB]@3LX$!`B(O)` M<7;B6XB9&8)^29`\G__3]57*?7YS[J>G],K_`)S,R/;\6@4@?YV2U=6L7-_9 MG_.;`^U^I]J]&S[$#'H[Y_2?R_M'I_0W_H?^O>FI>7EPY(RHR(OAB-;E7I8N M8CQ8I1L1!KBD=`(7Z_\`FI^O=.;F]#R<.IFHJFAC0![J_P!)2Q@_-]S-B%]4 MLO[7]7L-YC=6ST2!_P`$?2;_`)S&L>MA8?U2'3QAY?[.-AQ_MENWU`T"?9IC M["[]7V_S>_\`2)7^I,2#\X,3TNO7'_H*X1[PD"/DX9"]>&_UAX>';)O96'Y!)DFZPF_*=N_ ME9%EBYKZXMOBW]IOZN.F>LS8,5F$:=TM]#5MGVST_7V^G]K_`,/Z?_!K=Z`. MK"RS[>[.^W?^]ZZ%#V]#UN7S?X/_=LG5UKZ*LBBS'N M:'U7-++&'@M<-KV_VFKQ;#MN^K'UG8ZTF>FY)KN,?2JUJM>&_P#"XS_48O7N MM#..$1@.O;?N;!Q1CNLB?=[>I.9C;?\`IKS#KC>A?M7)_;5O5OVC+?M.ZO#G MZ#/3_F+O1_F?3_FU/RLA$3XK,"/50E*F'/&S#A($Q*XV:M)7TX]%_P`8.+CO MTH?EMMQGCAU5Y=Z&T_G;7V>@[_A&+UI>;Y0Z..B4?\X']1=A^DS]CBYN(W)X M']"^Q/LR_P":]+U/MWZO_,^I^E]);&/1]=/L0->;E!L#8V[$PSE;?S0^QW4& MT>KM_P!/7O\`](AG/'P\1X91%>H3'%_6'I78@(\7#Z@97H?E/6+L]3ZEDCK' M3NDX#P+[7')S20';,2O_A%]'MRL>JVJFVQK+=GI[_7_P"MH\N8QXZ) ME<:],9'Z_P!U&:)EP;1J0/J+Z\O'?KS_`.+/-_KX_P#YZQUZ54.J_L.P/=F_ M;]=KG-P_M/TO;L96_P#97T?WW_0_X1>==9;T#]JY'[7?UG]I;F^O+,/=NVL] M+;Z%GI_S?I^GZ2'*2$9R.LO21Z1*7^$KF(\48BP/4#ZCPK?XQLW(R/K-D8]S MSZ&$UC*&=FA]==UMH;^^]UGT_P#@ZUZSC448V/5CX[0RBIC65,;P&M&U@;_9 M7FGUJ;T8M8WK=G4&]9,[7OKQ'6"B!Z7VFK"NKQ'T[_6]'],S-_G=_P"@]-7N MFU?6-O1ZC]JZQ;TCT_T;,?'Q*\CTOS/2L?F9'4-NW^;].KU_3_F4O6]S=P9(W$$AO>!R?Q7EWUG;]2'.Z>.E6WTV>@ST78%;;6[-SO1^T,N MNQK_`+?ZN[_"?:O^Y7O]-=9]6!BCJ>4,]V2_ZQBMOK.SFULL.-(]/[#7B/NQ M&X'K?SOV:S^E?TO_``2&7-T96US+"!);F,N``!865H@````````M5H``+QG``"2,&UF=#(` M````!`,)```!`````````````````````0````````````````````$```$` M``(```(D!!T%V@=I"-D*-@N%#,<-_P\Q$%X1BQ*W$^(5"Q8R%U<8>1F8&K4; MTASO'B4?62"'(;(BVB/_)2,F1"=F*(8IIRK'*^@M""XH+T@P:3&),J8SPC3> M-?LW&#@U.5$Z;3N)/*4]PC[>/_A!$4(I0T)$7$5U1H]'J4C#2=U*]TP232Q. M0T]94&]1AE*<4[)4R57?5O98#5DC6CI;45QF77A>BE^;8*UAOF+/8^!D\68" M9Q)H(VDS:D)K4FQ>;6=N<6]Z<(-QC'*4<-ZR'O-?,Y] MS7[,?\N`R8''@L6#PH2_A;N&MX>SB*Z)J8JDBYZ,F(V1CH:/>Y!PD6226)-, ME$"5,Y8FEQF8#)C_F?*:Y)O6G,B=NYZMGY^@CJ%\HFJC5Z1%I3.F(*<.I_RH MZJG7JL6KLZRAK8^N?:]KL%FQ1[(VLR2T$K4`M>VVVK?(N+6YH[J0NWZ\:[U9 MOD>_-<`BP1#!_L+LP]K$Q\6UQJ/'D@#IP4L!H0'OPCG"@0+%@P<#1X.'`\9 M$!<1%!(0$PL4!!3\%?,6YA?8&,P9UAK>&^$:2)M)G4J?2Z-,IDVJ3J]/M%"Z4U>\5_U8/AA_&,`9`-E`67_9OQG^FCX M:?5J\VOP;.YMZV[H;^5PX7'>O>*5YFWJ0>X5\>GUO?F1_ M6(!-@4&"-8,IA!R%$(7^ANV'VXC*B;B*IHN5C(.-<8Y@CTZ0/9$LDAN3"I/Z ME.F5V9;)E[J8IYF3FH";;9Q:G4B>-I\EH!2A!*'UHN:CV*3*I;VFL:>FJ)NI MD:J'JW^L=ZUOKF>O8+!:L52R3[-,M$FU1K9%MT2X1;E&NDB[2KQ.O5*^5[]= MP&/!:L)RPWO$A,6*QI#'ELB=R:7*KW&O=>=Z&WY3@G.&BXJCCK>2RY;;FNN>]Z,#IP^K4Z^7L]>X$ M[Q+P(/$L\CCS0_1.]5GV8_=J^&[Y;_IL^V3\5OU$_B__%___```"!0/8!6@& MQ@@&"3(*4@ME#'(->`YZ#WH0>A%Y$G43*6(M9C5J/6Y%8QZAWN"?'Q]=GYO?VF`88%:@E(0^A36&*X)#(H"BO>+ M[8SBC=B.S8_#D+F1KY*EDYR4DI6)EH"7>)APF6J:8YM>G%F=59Y2GU"@3Z%/ MHE"C4J15I5FF7Z=FJ&ZI>*J"JXZLG*VKKKNOS+#?L?.S";0@M3BV4;=LN(>Y MI+K"N^&]`;XAOT/`9<&'PJK#SL3QQA7'.R8+*ILO*S.W.$,\RT%31=-*4 MT[+4S]7KUP;8'MDVVDS;8=QTW8?>F-^GX+/AON+'X\WDT>72YM#GS.C$Z;KJ MK.N;[(?M;^Y8[USP6_%6\DSS/?0J]1+U]O;6][/XC?EB^B_Z]/NQ_&;]$?VS M_DW^X?]Q__\```'9`XT%"094!W\(E@FA"J0+GPR3#8(.<`]?$$P1-Q(A$PD3 M\!36%;L6GQ>#&($9?1IT&V8<51U!'BP?%R``(.HATR*](Z8DD"5Z)F0G3B@Y M*24J$"K]*^HLURW$+K$OGC",,7DR9S-5-$0U,C8B-Q$X`3CQ.>(ZTSO$/+4] MICZ8/XI`?4%O0F)#541)13Q&,$E5M5E]745A#635:)EL87`E<^EWK7MQ?S&"]8:QBFV.)9'AE9F949T)H M,&D>:@MJ^&OE;-)MOFZJ;Y9P@G%L>H9[;GQ6 M?3Y^)7\-?_2`VX'"@JB#C81RA5>&.X<@B`6(ZHG/BK.+F(Q]C6*.1X\MD!*0 M^)'>DL23JI21E7B68)='F"^9&)H!FNJ;U)R_G:J>EI^#H'&A7Z)/HS^D,*4B MIA6G"*?]J/.IZJKBJ]NLU:W0KLNOQ[#$L<*RP;/!M,*UQ;;(M\VXT[G;NN.[ M[;SXO@2_$<`@P3#"0,-2Q&;%>L:/QZ;(OLG6RO',#,TJSD?/8]"`T9_2O]/@ MU0/6)]=,V'/9F]K$V^_=&MY&WW/@H>'/XP+D3>69YN?H-NF&ZMCL*^V`[M?P M,?&0\N_T3?6J]P3X6OFK^O;\.OU[_KO___\`@`"``.6T?\U_5,P_?Z5^P[*, M?Y1^:9A_?YY^3'WC?\%^8V)!?_Y^DD1A@']_!1]D@?Z`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`!]L;[-AP5]5Z:UAC!],XX:A81] M2'30A/Q]C%IKA)M]Z#V.A)]^BQB+AGJ``>O)AZZ)"-4`AJ.'?;V-A;F&(:5^ MA/B%`XS0A&2$*G-]@_2#B%D/@ZB#!SPY@[B"X!;YA7>$`^G[AG"3^--3A7>1 M=;P0A)R/&:04@_6-$XN)@W6+5G)5@Q>)U5?_@MB(?#LL@NN'E!6(A'N'J.A2 MA7.>^-&RA(.;@;I_@[*8.Z*A@PZ5.HHX@J"2H7$I@E"00U;W@AN.'#HT@BZ, MEA0X@XF*R>;(A*JJ&-`R@[NEK;D&@O&A@J$_@E6=I(CN@>.:$G`+@:.6YU8" M@763_SE3@8:2#!,5@IJ,Y^5CA`RU8L[6@QVP`[>U@E*JZJ`%@;FF+H?5@4ZA MQF[]@0F=O%4?@..:,SB)@/.8.!(?@;R,0>0O@XO`VLVL@IRZ@K:2@I[T M@3:NWX;H@-.IL&XQ@).D[51<@&6@V#?=@'2>6!%4@0.+M^,I@R3,E;03K3$@1/(89TU@'3!%(5.@!*Z>FS5?]^TS5,\?[JP2#;1?[RE M$!`J?_2*[MT\DF%\F,=KD'I\0[%6CK)\$)K'C1I\$8.7B[=\26N>BH)\L5)U MB8A],C:.B2=^`1$RB]9_WMM&D2V&R\8%CT*%A+`JC8.$;YFRB_R#D(*#BJV" M\FJ,B8V"B%%>B*."0#5ZB$F"8!`$BIB#AMFSD`"1),2=CB*.[:[]C&.,WYB` MBO&+)H%5B;.)LFEJB*:(?%!*A\N'=C1VAWF'!0[ZB5:&N]A'CPB;DL,NC3*8 M>ZV!BX:5EY<>BA.2_8`7B.B0OFA3A^:.O$];AQ.,_S.=AL*,'0X4B"B)A-;I MCDJF%<'1C'BB)JPDBM2>;VDVU MA=V8^3(LA8J7\@RHADN(C]20C3.[I;^2BV>V!:GRB<*PII.^B%NKI'T*AS"G M"&6>AC:BYTT,A5^?KS&=A0N=/PP>A9>(,=.CC,O&Q[ZSBP/`2:D6B5ZZ%)+G MA_2T27Q"ALRO!&3VA=RJ=TR'A06G93$DA**A.@NNA02'YM+@C'+25[W[BK#* M\:A=B0W#X9(QAZ.]4WN=AGJW?&1IA8NRQTP-A+VN9S"WA%R@\`M5A(Z'JE&![)GD5DD5[>&)ID&5[^4IRCMI\DR]CCC5] M?@I^D!]_P,LZFN*$_;=FF".#YZ,!E9F"_(WZDTV"2W@KD4.!V&%\CW6!FDE^ MC?>!@2YYC5>!XPG/CIN#",G3F=^.K;8%Z,BHF.>8CK3CECV5SJ"GD[V3-(N[ MD7*0[78#CX:._U]_C=*-4D>QC&:+^RS>B\R+S0BOC!^%W\=\F"RBAK/&E82> M^I][DPN;K(J$D-*8JG3LCMF5]%Z/C3&3H$;NB\61Q"P[BR>1O@@\BR&%D<9? MEYNLI;*RE/6H69YLDGZD2HF$D$J@C70!CE.=(UVXC)V:)T9!BS27]RNNBI27 M.P?;BDR%4,5FER:V[+')E("QWIV)D@BM#HBJC]6HFG-`C>6DCUT3C#"A$T6Q MBK2>TRLZBA*;R`>+B9N%&L22EL/!>+$'E!Z[I9S)D:>V%H?NCW*P[G*/C86L M55Q]B]JHF44^BERF02K9B:B<^0=*B0N$[L/BEF[,>;!GD\K%V)PHD5:_A8=. MCR.YLW'^C3:TJEP#BXVQ$T35BAJL0BI\B6FJH(*6SQEUV')U>*E.^&9D"\ MDNZ%Z":.DCB&6P0OD+2"U+E\HQN5]:;]GZ.3>I/_G%F1.8!?F4Z/,VOUEIV- MD5:ME#2,,4`"DC2+.27YD7>+V0/]CY*"LKB6HE6?:*8*GNF<,Y+^FZJ9/W]6 MF*:6BVL$E=B4+E79DWR2/S]2D7Z0["5ND+^15@/3CIF"EK>CH&6HYE5:;(E4BDNN8K#[#D.R7/R4!D">6"P.OCRO:1MG>&N'I%LFIVIQGW*EZ"ET6F6E.NB4E26DH"?@SY/D&R>5"2LCZ"8 MS`.1C1J":;8/H/Z\MJ/&G8*W89#*FCVR7'TLES^MS&D!E(ZIX%07DBVG#3WO MD!*DPR1ECS"8FP-YC(V"6;5QH*_'+*,\G2W!%Y!!F>J[7WREEO"V/VB(E$"R M$E.SD>"O1SV;C]*IJ"0?CO28;`-EC!V"3*X>K_YYY)PIJ]YYMHH0I]YYLG>* MI!=YYF1'H)AZ4$_YG7-ZYCH?FO9[C2`IFIA\<0``E=-_RJS.KRB"@YMHJN2! MF8E^IMJ`X';[HQ.`8V.HGYN`)D]3G'^`(SETF@6`3!^AF9:!%P``E(Z``*O? MKCV++IJ*J?Z)C8B]I>V(&G8QHC"&^V+DGKR&($Z?FZ:%CCC5F2R%2Q\NF*N& M1@``DW"``*L2K6J3YYFJJ3>1FH?,I3"/A'50H6B-O6(2G?R,44WHFNB+.#A! MF&J*HA[*E]>+LP``DGB``*I!K,J_E[B0:QYUEQ2080`+D9*`!ZF0K"RES)@OI_RB,89(H_F>XG/* MH#6;[V"JG+*97$ROF8^7:S=-EPJ6Y1XHEE^46``;D,2`$JCBJ[FO`Y>BIWVJ MN(7"HW*FPW-`GZRC0V`IG#:@3TQ!F1R>.S;VEH"=?1WSEX5#HPVNYW+(GTBJY%^[F]:GJ4OAF,6EXS:PEB.BZQW,E4^4 M)@`SCX^`(J>YJQ7"7I:FIL2\JX36HK:W<7)BGO:R^E]CFX:ONDN9[!Q?PHG)[O@``D2B``)ZFN;:!I(Y"M,*`O7UBL`6`#6OS MJXQ_GEFXIV1_PH3N`N@``D&Z``)WWN,N)U8V:L]Z( M27S/KQJ&[FM5JJ.%[5D>IGJ%-$7AHL:$S##ZG^R$Q!>!H!R&!```C\N``)UH MM_.2$(SXLP^/YWP:KE*-^VJJJ/J```CEZ``)O(MC:KH(MPL42GI7J8K(*D$VDO MJ`2A!5ET0YH`B=22_$G/"<)Q<5G*B/FP``C@J``)M*M=>TC(LBL-2O MVWI7K`.KJVCIIWFH,5;?HTNEL$/\GY6DGB^/FP``C<6``)K9 MM8:]ZXK+L'2X@WH.JZ&SMFBLIQNOXU:RHN^MH$/?GSBJIR^1G"^@*1N)Z%W&#; MLW6$\T^AKI^$63U2JEJ$&2DCITJ$3@^OJ$^$[@``C,&``)"!PJF0:X#HO2.. M7W#IM[R,E6!KLH:+)D\ZK;**)3T`J6J)DRCVIDB)XP_:IP2)`@``C(R``)`L MP>B83X"4O%N5M7"2MO"3=&`+L;N1E4[HK-:0)CS#J)*/:2C7I6.0&Q`$I>&* MU```C%Z``(_'P5"@8H!"N[6=-W!-MD":WTZ)JY.= M!SQ]ISJ0248AM16/)#3$L%6.WR%:K2"/>PG,K$*&H```BEB``(0= MR]2>(750Q:2;&F8HOXZ8D%:#N:^6F48XM"^52S3CKUV52B&2K!B40`HTJQN& MY@``BFB``(/^RRRESW5*Q.^B.68WOLR?.U:AN.F<_49T9YBMKW>YQY MI<+]>_9YT:I]?%AZ')%P?,-ZBG>[?3M[%ESV?<-[JC_6?GA\7!L6?]%]#_!< M>9"$[]DZ>@>#Z,%Q>H"#!*D5>OZ"3I`=>X6!R'9Y?!>!9%NZ?+*!"CZ7?6>` MU!EU?E^`V^YJ>":0=-=H>*R.4;_7>3>,4:>2>FF))74W>Q&'U5J1 M>[J&E3UV?&N%B1?V?.^%&.R8=OB!J5T:8!>+R3#8U2>6^0 MIG/U>B>.:UEU>MN,33QL>X6*@A::>XB(W^KP=@6GH]0`=I.C;+R*=RV?;Z2% M=]>;N8OO>)&81G*^>5J5+%AG>A>2.3MU>K>/U15D>E>,%.F"=4NS4M*9==6N M(KLI=FRI**,U=QFD?HJ]=]J@(G&8>*><$U=L>6N89CJ6>@*5KA16>6>-P.A0 M=+F_'=%M=3VX]+G^=!:C3E:1>-B>ZSG6>6:< M*A-R>*:-)N=7=$S+"]!Y=,K#ZKD&=5*]`*$9=?FV=HC,=L2P:&_H=YZJX57G M>&2F'#DS>..AT1*Y>`B,J.:1=`/7*<^X='G/#+@Z=/;',:!%=92_R(?_=ERX M]V\O=SBRZ%5&>`"N+3BF>'>F31(E=XN,1.'CA"YWY@3"`'C?N@8.`+!)X@R"`IMZ$ M@4J-J\E.@.&+WK-1@(>*+YQG@%&(PX34@#*'C&R&@"Z&@5,,@$"%CC;G@(V$ MXA$\@;*$<]SG@"J8E\>D?\65U;&J?W:3.IKJ?T:0U(-\?SR.PFM8?TB,WE(( M?V2+)#7Z?ZR)X1`K@'6'P=M@?SVCDL8D?MB?ZK`R?I"<:YF!?FF9)((O?F&6 M%VHZ?GZ3:%$5?J.0\S4A?N*/2@]`?V6*4-H-?H6NK<3:?B"J)*[M?=6EO9A+ M?;&ACX$5?;"=J6DR??C*57PY[?H")RMCS??.YZL/(?8ZT M@:W:?3ZO,9<\?1BJ((`C?1ZE;VAA?3^A)T]\?6>=C#.X?9F;9@W8?<.)7-@0 M?87%6<+K?1^_#JSR?,BXUY90?)FRXW]$?*"M;6>=?,NHE4[:?/>DV3,L?1N@ M6`U3?2B)`M=D?371%\(\?-#)YZPP?&["QI6"?#2[]WZ$?#BUS6;W?&6PETY4 M?)>LEC*Z?+>B3`SH?*V(NM'!C5%VDKVUB^MW!JD#BJEW?I-^B8YX"7TQB)=X MLF8%A\5Y>DV>ARAZ23(XAR5[,0S6B21\>=`\B_&`Q[Q\BIF`/J?:B6-_SI)H MB%5_?GP?AVY_5V3[AJY_44R4AAY_7#$UAAI_F`OLAXN`6L[BBJF+&[LAB5^) MG*:LB"N(-Y$OAS"'#7KRAEB&$V/BA:F%1DN/A2:$EC!$A2&$1`L>AB2#PLU^ MB8^5=;FQB$F3%Z4FAR60VH_-ABZ.SWFQA6R-"V+'A,R+=DJVG>"@^^; M;V#3@UB87DC[@NJ5XRX'@M"5#0E1@P"&3,GYAW*U&;8WAC&P3J&QA0^KEXQU MA""G&G:G@V:B]V`7@M*?1TA5@EB<=2U[@CB:20CF@D:&!,DLAP.__[5MA<6Z M9Z#?A)^TWHNA@ZFODG7>@N^JPE]G@F:FI$?'@>VC^2T$@;J><`B/@:Z%RHKJ@TNX:'4U@HZS`%[5@@:NM4=*@9.JUBR7@5Z> M)@A*@36%F\('EKUUA*]9E(IV"YP-DH-VEX?PD*YW-G+XCP=W\UT&C91XRT6Y MC')YIBL#C$YZC`:IC/]\G,"\E7U_+*Y3DU!^RYL4D5-^?HU^ M3UP(V*T8DC2'G9G[D#:&=87D MCGB%B7#_C.J$QELHBY*$+T/QBH&#NBECBDV#N06^B@J#)KYODT&2IZODD2B0 MF9BYCS>.H83(C7",XV_KB_2+9EHPBJB*'$,9B9Z)$2BJB66(YP5?B->#H;U' MDF>9CF&7`X.5C*J4A6[9BRB205E`B>N04D)3B.2.QR@(B*". MR@4-A]"#:KP\D;^FAJG%CZFB^):0C;R?AX*7C`><2FWPBH>945AMB4"6NT&G MB#R4WR=\A_"4.P3(AO.#/+M;D3FPIZCICR6L7Y6TC36H+('`BWZD-&TLB@2@ MF%?&B+V=@T$9AZF;E2<+AU68O@2/ACR#%;JDD,^[`:@VCKVV`)3YC,JQ#X$$ MBPZL7FQYB92H,%DUT"=AT"BW":JAM::)`1@A::"]KH:D'S%NJ>GCFW` M`Y1;C'BZ4H!@BK:T\FOBB3>P3E:GA_NM$D`MANRHQ"9(AH&9X@0[A2^"W;+# MH'ITPZ%(G8AU3H\\FL=UXGQHF#UVC&BQE>EW4U/HD]IX,CVADD5Y#"-GDDEY MU`%*D%E\NK&PGV!]YJ!]G&M]F(Y\F:Q]8WNJER1]46?LE-A]9E,DDM)]G3S; MD4!]X2*YD3-^5`$LCLQ_W;"[GD:'#I]YFUR%](V/F)N$^7JVEB"$,V<%D]V# MG%)0D>&#,3P=D%."[B(>D#6#.P$1C6^`N:^\G5.0,9YHFFV.8(QNE[2,MGFW ME3"+,V83DOJ)^E%^D06(\SMNCWB(.2&5CTJ(LP#ZC$"`J:[5G'"9BIUVF9.7 M!(MREN*4IWBSE&62-W"$7CFV.+P#FBSV`G*WS MF\RC")RLF.Z?T8JIECB2 MX`#6BF.`D:TRFTVLH)OLF&^HP8GHE;>D_G9D]NCPJ;\3G" MC6J;`B!5C1:5W`#(B:Z`AZR0FNNV:IM0F`VQXXE(E5&M=7:%DLZI5F,@D).E MRT[FCJ>C2CE9C0"A6R`,C)"5JP"]B1N`@*P4FIS`G9K3E[Z[;XB^E0"V5G7W MDGBQHF*?D#FMS4YZCDRK73C\C*ZF91^^C#Z5=@"TB*6`>J0)JI%T.9.?INQT MO(*QHWQU3W$%H$5U_%YSG4IVQ4J\FJAWHC57F+YX:QM`F6MX[```C9Y_$:,P MJ99\XY,+I>=\FX(DHG!\!H3EAJ(.```BG>``*#CIM26YI"7HS64FG^IG\*2?VX" MG(B0GUN@ECF3Y3*[E#N3B1F$E%:0Z@``B0>``)^= MI:&H\H]GH@6E9WYWGHJB!FS(FT:>\UINF$Z<6TEGUE^"CE$:^E4RB#C(1 MDRZ?=!DFDQ"1`0``B`N``)ZJI/F[WHY]H52W(7V$G="RBVO7FH.N>EF0EX:K M@T9LE.^I0C'.DMBAK!CWDK60X0``A["``)7QM0ASQ(9]L+AT-W:0K*)TPF7O MJ,5U;%1GI2MV,4&BH@AW`RSPG_AWK!)NHAQWK```B7Z``)55M")\`88?K\5[ MM'8TJYY[D&6.I[)[EE/[I!%[R$$XH.E\&BR/GLE\:1)4H)U\KP``B,2``)35 MLQF$+(6,KL.#-'6PJI."963\IJF!V%-OHP>!?T"]G^"!6RPOG;2!9Q(_GS^" M"0``B"&``)1.LA^,4X3LK<^*PG3[J:2)8&19I;&(/U+6HAB':$`]GO*&V"O2 MG+J&P1(KG@:&R@``AY.``).[L5.4DH14K022<'19J-R0B&.RI.F.WU)*H4"- MA#_(GA^,H2N!F]N,J!(;G.Z*X@``AQF``),JL+><^8/+K&::2W/4J#B7U6,O MI$&5K5'.H)23Y3]FG5F2PRM`FPN3$Q(0F_*,-@``AK.``)*^L"6EA8-@J]6B M2W-HIZ6?2F+&HZVBL0FD:8E!()FPR,,@``AEZ``))3 MK\6N18,;JVRJ>',FIRRFXV)XHQ^CR5$=GVVAC3[.G#V@NBK:FS$7+5IM"N\6(JHK^K?%#F]2FS2J\ MF62:,,```A>*``(AVO^5S47GANO5SK6K9MD-T*ULGLOP5[+GFYN@AZU&JNM3QZK%KT ML*MZMDI/K&YZ[CA?J-5[0R0TIL=[@0J?J"Y\8@``A;:``(?>O?*"Z7EBN/V! M]&I>M":!+EJ6KX^`M4GVJTR`=#@:IZR`;"03I8&`E`K?IH.!)@``A6N``(>7 MO.>*F'D!M_6)&VGGLR*'U%HLKH&&UTF4JD&&+3?/IIV%U2/RI%N&&`L7I0>% M40``A2F``(<^O`J28'BEMQ:08FF$LD&.IEG`K9Z-,TD_J4Z,'#>/I:R+EB/7 MHU:,/@M*H[F'H@``A/&``(;?NV*:4WA0MF>7UFDUL8B5G%EUK-^3O4CYJ(R2 M53==I-.1QB/#HFN1Z`MTHI2'OP``A,*``(:'NMZB7W@)M=J?9&CUL.^MM]TRR]%LR%U9!L& ML?AU:P-OL$UWB0``@R2``'MHRD!ZB&VKQ,)Z$5]>OVMYV5!PNDEYVD"9M8=Z M#2]2L:AZ5AM'L#%Z7P0+KB]\1@``@R*``'MRR1*!V6V7PYZ`V%]'OCV`#U!. MN0M_H$!]M#I_;2]0L$=_=QM]KI)_JP27K$F`=0``@R&``'MPQ^B)%&U]PG.' MGE\7O1&&9U`EM]2%A4!>LP&%`B]*KP*$WQNMK1V%A`42JIN#;@``@Q^``'M; MQNR096UEP7".@%[^O`2,Z%`"ML*+I4!/L=^*SR]0K=R*K!O?J]"+,`6!J22# MN0``@QZ``'LYQB67Y&U4P)J5D%[WNQ^3CE`#M=61]D!/L.Z0["]AK-*1`1P5 MJJ:0"P7DI^&#^P``@QV``'L7Q82?=6U'O^J1Q+J:.3(08[ILZ$-P``@QV``'KVQ0:G,&T_OUNC_5[\N<&A+%`6 MM&&?%$!GKW6>62^-JU:N$:@``@QR``'KDSB^YJK"@11RSJ#&39P;(I4:$E@``@QR``.8? M=G!S&-`;=TMS\;F`>!]TS*(J>.IUKXHD>;)VH7%C>G]WHU>&>T]XGSLO?#%Y MEA:=?2%YZ.0/=(=^:,YK=8E^&[?Z=GQ]Y:#+=V5]RHC=>$M]S7`N>3-]Y%9; M>A5]^3H'>N]^$A4@>U1]P>(Q`:$0E4^>/:#>3CY><2"Q!/$>=6""^!I<9.5.,K-:,=FVR=O:*PE0J=_*)(3?^>+*'MQ*4>(N%[-[)<'6@G1:5,C=PN.^C<5=[N,_A&/=W&)/]UL M;YBL#H-W=`^;M&M8=368,U(N=D&5#S9"=N&2 MQ1"T=H2+2]Q.;NNWC,;!<`2R6["+<16M,9F^S3T=86>M0]J=1^*;-K+;AO.QL5$;RG'Y*[K<"'`\Y?_ M<2>Z-H"[JO.?9=\?)7^??HU]-#.0?Q)] M<@Y!@$A]@],`>]*'4+\'?`*&0JI!?#.%1)2!?'&$;WW^?+N#O6:B?16#)DX+ M?7:"F#*3?>V")0U,?M*!@]%N>H:2&+UE>KR0&:BA>O>.,),->T",:7RJ>Z&* MW65X?`R)7*:J:"Z>V709&D M>C^4F'MF>J62'&1;>R*/YTP9>Y.-X3#<>^J,?PO"?'>'\\ZS>)NGTKJS>-2D M'Z7R>16@<9!R>6J=:9D6-6>E.6A$L^>LR3YC`A>Q62@@LI>XV'B\VN M=_&RT[FP>"JN3J3J>&6IOX]L>+FE5'E:>2RA-&*%>:Z=<4J$>B&:2R^#>ER8 M<@JJ>LN'-LSD=W.]\;CC=ZJXH*00=]RS-8Z+>">MZWB!>)NI"6'$>2>DMTGE M>9RA:R[\><&=3@I">BV&\,Q5=Q[)/KA*=U'#(Z-?=W>\X(W+=[6VPG?(>"2Q M+V$@>+"L>TE4>2>H\BY]>4&?;PGP>:^&N,9^B!APBK/\AS-QOJ"2AG)RVHP; MA=%S[G:WA4=U"V!Z@VA\:2S8@[)\P`@OA*I]=<02 MA0Z$^;&HA%R$,9Y?@[.#8@SF!"\*M@\>/*K`Q@Q:-C9S)@GR+]XAQ@@"*?'-"@:B)-ETU@6N($D75 M@4J'$RLL@7B&?@<4@?B$*,%4@KV98:[8@@V6_9MU@7J4G8VCOJVX@4"@EII7@*N=9(84 M@#B:17$76EM1?[:4PD1$?Z&2M"G7?["2$P9$?_Z$/;]$@4FN-ZS+@)^J M3IED@`6F2X4@?XZB6W`]?T2>N%J2?QB;@D.F?O:9(BE1?OB70@7V?S^$"+Z0 M@,ZXVJP0@":T,IB9?X2O8(1.?P*JGV]S?K>F3EG8?I6BJ4,,?G>@<"C??EZ; M@@6V?J.#W+X4@'C#P:N"?].^8Y?L?R2XP8.3?I.S-6[&?D"N25E%?B"JG,"AY?>:;7@6#?B:#NK=3BI5UAD#OB>!VI":!BCMW@0,JBB1YO;98C^%Y4Z5#CD=YGI,>C-1YZ7_Y MBX=Z/VO6BE]ZJ5:JB69[)$`*B+5[F"6RB/I[]`+;B(1]:;5)CHN"ZJ0,C0*" M79(#BY*!TW[7BE.!:6K,B3>!&56[B$J`XS\VAYZ`NB3ZA\Z`N`*5AQ:`HK0L MC4V,E:+4B\N+/I"VBFJ)Z'VYB2J(M&F]B!^'K%3.ASZ&QSYKAIBÒAK:% MY@)9A=F!EK,%C$N62:'"BLN4.(^1KB,LA.R1(0'Y@^6!5K$UBNFJ#I_KB7&FEHW`B`^C#7J\ MAMF?G6<%A=6<>U)JA/V9U#QUA$J8/B+`A#"5G0'5@R>!/;"2BG*T)Y]`B/ZP M`HT)AY:KOGH"AE:GEV91A5"CX5'&A(.@]#OP@\Z?7R)A@Y27/P&X@HV!*;`@ MBAJ^BYZ\B*JYPHQNASNTQGE=A>^O[F6YA.*KP%%$A!.HYCM_@V2E,2'_@R*6 M_`&@@A*!&:B;FNEO")B.F'-P08>EECQQ:76PE#QRC&*UDFASMTZ2D-5TYSC4 MC\)U]!ZCD(9VA```BG)[1:?*F9UX)Y?2ESUX@(;7E0YXW73DDPUY1V'KD3MY MQ4W0CZQZ4#@9CI5ZS!X&CS5["P``B-E^DZ;OF%>!.Y;1E@F`RH7ID]N`97/M MD>6`'&$%D!U_\4T!CIA_WS=CC8%_UAUWC?Y_\P``AW*``*7UES:*0)7"E.J) M'X3&DL>(#7+VD,V'#V`;CQ.&04PYC9:%E3;`C'Z%&QS\C-V%9@``ACN``*4+ MEBZ3<93.D^R1HX/+D="/XG'VC]R.,U]&CA:,LTM^C*6+?38JBXR*KAR/B]"* MXP``A3"``*0TE6^H1F_' MC@2DIUTMC$2ABDFFBL^?9#2TB9B=V1N+B8>2GP``@OV``***E!:YFI)(D>"U M6X$CCZZP\V\XC:&LOURJB]BI4DDWBF"G2#12B3"BUQLWB1B29P``@H2``)I2 MI-MNA(L\H;IOKWM9GMUPTFI[G#AQ]%B5F<9S&T5NEZ]T/S!REF5U*!7_F$UU M*```AB!^:9FRH[MW+HJTH*1WA7K#G<%WZ6GDFQ%X7E?\F)MXYT3=EH)Y>B_J ME2IY[16FEM1YW```A0"``)D+HH9_P8GJGWU_7GH*G)9_#6D?F>U^X%=&EWI^ MT$0[E69^V2]BE`=^Z!54E7A_"```A`2``)A*H66(2HD-GF.'1'D8FX:&4VA. MF-F%A%:`EG.$XT.3E&2$:B[>DO^$*Q4'E#Z$@```@RB``)=^H'R0W8A#G7R/ M0GA'FJ&-O6=TE_>,6%71E8&+&D+\DWN*-2YLD@R)T13*DQN)0```@FR``);7 MG["9JX>7G+F7>G>7F=^55V;)ER^34U4OE+>1C4)[DIN00"X,D2>0#A22DA2- M1@``@DY6? M44&'D8*>$"U8C^F;X!0YD(2-K```@."``)5UGF*T\(8[FVNQ*78BF'BM1F5! ME:JIKE.TDRJG#D$OD1*E.BT.CWV>=A0"D`R-AP``@(N``(R$G)EXY`TZGN)X MT0``@<6``(NZK0U^77USJ5A]_VY\I<)]NUZ+HFE]HDVGGU9]J#MYG,=]QBH\&+M%U! MH&**@4R)G4R)B3J-FL&([":4F3&(_PT_FER'/0``@!J``(H0JD&6Q'NNII:4 MS6R8HP62[%RZGZ&1.4P)G(6/T3HRF=V.]"9;F#^/6PU"F2>(]P``@`"``(FH MJ9Z?('M`I?B2ASEOXGF*?(TM*FSF=.3F*F)FEP@$29JF!QC3,!IY-R>!Z[IM%RP06]IS]S;0``@`"``'\SN1]U4'''M,EU MC&.1L)YUZ52*K*EV8D1VJ0EV\#+KIB9W=1[$I3!WD@8@I2%XQ0``@`"``'[Y MM_%\_G%OLY]\G6-%KV=\7E0SJVA\5$0JI\)\:S*VI-5\EAZYH[5\H09RHS9] MHP``@`"``'ZJMK^$DG$%LG&#L&+&KCV"\5/*JCB"9D/)II:"%#)RHZ2!\!ZD MHF*"%@:VH7^!Y```@`"``'Y,M;^,.'"DL7**X6);K3Z)L%-5J3>(K4-TI8:' M\#(QHI.'GAZ0H32(*P;QG_J$L0``@`"``'WPM/Z4!G!/L*V20&((K'&0EU," MJ&*/)D,EI*J.$C'^H9V-M1Z!H".-X`AY^GRZ2IP=.G7B$\0``@`"``'UJ ML^FCY6_8KXZA4&&0JSV>S5*&IQN@F\6%*```@`"``'*OQ4ALWF6EP*QMM%@=O#ENGTG3M^QOE3IUM`%P M@2E3L31Q+126L>EPN```JRET>P``@`"``'*BQ'=T<&7#O[%TBU@ZNP1TU4GQ MMH9U0#J6LG9UORF-KW]V(145K\1UNP`/J>EXYP``@`"``'*CPSI[N&6JOG)[ M15@FN;5Z_4G6M21Z]SJ(L0-[$BF>K?)[.!5NK=Y[!`"CI]-]+@``@`"``'*5 MP>V"VF6`O2:!^%?GN&J!0DFHL]*`S#IFKZV`EBF(R%?`MT6'MDEULJB&VCI1KG.&42F>JT>&217M MJJ^&D`&1I%6!#P``@`"``')1O_F1:&5*NQ^/RU>RMDZ.5$EGL:B-(CI!K6R, M7BFHJB&,A18GJ5B+@P'QHNJ!4```@`"``'(POU"8TV4_NF*6X%>NM7^5"DEC ML,^3C3H_K)"2PBFVJ3B3!Q9@J"V/(0)'H;2!B@``@`"``'(3OM.@8&4]N M&E>QM-6;[DEDL!::.CHZJ]*9MBFWJ'V8>1:%ITV/.@*-H+.!N@``@`"``''^ MOG:H-F5#N5"EHE>[M$.C*$EKKW>A:SI%JRF@42G0I\J<11:HIH^/4@*ZG_.! MV```@`"``-FU<8%LJL4.*!U@C9Z>:!VP!(">GEVK=>W;U=WWL-P<-QX1ZY)"%[/A#.>,)ZK=7B;82#'<&D;QN"9ZRU<)F!PI;, M<@"!28`<6`2C1L=KQ_[P_`=T%_(M09:^J.2K_5;8Z, MD*KN;QF*\)4Z<)>)=7ZP<@Z(,6=7* M&`X.=-2&J-$F:8JDG;SK:SBA(Z@";,^=JI)A;ER:47P<;^B7*F4*<6B4/TSC MKBJ;K:_FG*Y%);86BYWL8;QB> MYF0F<)^;,TP9<>B7[S$Z M;-:KF'HO;FJFQF-7;_BB;4MP<4.>R#"J<9>;D`QG()>1KB[=]>F1M2Z/!>N9NZX\">VAP='E5>^YQ^F*U?'QS?TK2?15T[B_A?=!V M'@LY?V1V-\CI=^AV/+97>)%VY**D>2UW@XWL><1X(GA">EUXRF&O>O]Y>DG9 M>Z)Z&B[U?$EZD`IK?;%ZJ,=E=BJ`Y+2N=N:`AZ$<=Y6`+(QS>$-_Z';R>/5_ MN6"%>:U_F$C/>EI_N5_0`FV?#-^UL73=*6+>K,+=6N*,Y]X=B>(\HL# M=N2'Q'6B=ZZ&OU]?>'B%T$?5>2V$[RTP>9R$-`D9>NB"=\1;/S71E=HF-X5Y(=V:,+4;M>""*G2QL>'*)B@B3>5,UU+=G22KD8;=S20BRN]=VN/ M>@@B>-V%@,(K<8^K?J]F55P?$>!>%0,%NQV9KZ:(P=X=W:%#<#P<)3!-JX7<5Z\`YI2<@FVB876 M=(2H"$0[=3NE$"HJ=2.<@@<[=O:$Y+MN@I1JG*HQ@CAL M>)?K@?EN*H1Y@=%OOV_\@;EQ35IP@;ARV4.`@=UT1RD$@H%U4P4\@[MVC;I, M@+UTLZD0@(UUC9:S@&5V5H-/@$MW%V[E@$)WW5EP@%!XID*3@'AY6B@N@/QY MR`3(@@QZTKD\?92(U:9V*=#*/S>UZ: MHY&H>UZ8'GYU>VZ5FVIY>Y63/%6*>\^1'C]&?`F/=25H?`^/``-^?4&"7+1U M>IZG2:,->IVD)I"\>IF@U7V*>J>=B&F@>M2:=53.>Q*7OSZL>SZ5QB3L>RJ4 M(`-)?'V".;/,>@NQH*)8>@RMQH_X>?^IKWS">@2EF6C<>C&AW50:>GF>NCX9 M>J.FJ84@,>>]V"'+-<>:>\(*'2>:>WF(]6>8VROGP4>8.MZ6@Y>:BI MEU.,>>ZF03V7>AJC?"0+>UZ"!*S8B[UIVISYBH!KNXO]B7YM<'G` MB*EO"&9IA_%PF%'LAV)R)#OHAR!SA2&QA_5T3@``AX%W)*OSB@)S99P'B/AT M58KNB`QU,GBYAS]V"&5QAHUVXE$'A@9WO#L1A"#VAFIXQP``A95[%:KP MB&I\VYK5AWM\^8G9AIA]"W>=A=I](61QA31]1E`IA+A]=3I1A')]F2!5A/1] MD```@^9^BJG1AO:&6IFDA@^%MXB0A3Z%`':+A(:$4V-Y@^V#PT]<@WF#23FF M@SB"XQ_&@YB"N```@F^``*BEA<./VYB8A.".BH>#A!>-(G5B@V>+MF)O@M:* M9$YK@G6)2CCA@C*(;A\R@F:(>P``@2Z``*>KA->9?I>6@_J7?H:!@S"57'1O M@H"3,V&,@?&1,$VJ@8:/>#A%@46.4AZU@5B-W0``@""``*;BA!RC,I;(@T6@ MB(6M@G:=K'.9@<*:RF#$@3>8)DT`@,V5\C?'@':4NAY1@&R25P``@`"``*9* M@X^M")8C@KZINH3X@>>F)G+A@2:BC&`2@)>?5DQ3@#F4 M1```@`"``*7C@RVW&I6D@F"S,X1>@7RNZW(\@*FJH%]\@!"F[TO7?Z^D>C;- M?UBA>1V>?PV4!P``@`"``)ZFE1YI3H_4DR9K(W_ND7ELU&[,D`-N:ER-CK!O M]DD/C9UQ=#/6C1!RLAF'CJ)R]@``@Q9ZO)WLDY1R6H\6D.BP%\7S)^BF-\D1A^BWQ\;```@%J``)P9 MD+>$*XS]CPN#LWSVC7Z#-6P)C!""N%GZBM:"6$;.B=.""3'EB3"!S1@1BA*! MV0``@`"``)LFCX2-+(P`C>*,$'OXC%Z*Z6L(BO:)OUDMB;6(LD8'4!>PB,:'6```@`"``)I2CJ"648L_C0:4F'LWBWZ2Q&HUBA20\%A>B-6/ M1D5MA]2-\3#+ARF-31=)AZR,!0``@`"``)FDC>^?@HJ'C%J=,'IYBLV:M6EZ MB5Z8/5>MB"&6"D35AQR46S!>AE>3]!;_AK*/C0``@`"``)D&/80``@`"``)B] MC0BR5HF$BWNN\7E6B=RK.6A.B%*GD%:1AP:DE$/5A@2B]B^&A3B?'19KA4B/ M*```@`"``)#8GN%HS(+7G$QJC7/?F@)L-&/$E^]MQ5*'E@MO23_LE(9PL2M* MD^AQLQ!LEMYQ+P``@`!]T)!`G8UQ8X)(FQ!R47,\F,-S.F,FEJ-T(E'PE+9U M##]EDRIUZ2K3DG5V>A`XE/5U\@``@`"``(^8G"%YV8%UF;IZ$G)]EVUZ36)@ ME5-ZE5$]DVIZZ3[+D>%[0"I9D1Q[<1`&DR][)0``@`"``([/FLR"/8"2F&Z! MVW&$EBV!>6&0E!.!)E![DC>`ZCXJD+.`PBG>C^*`J0_2D9*`J@``@`"``(X` MF;2*J'_&EUF)N7"TE1V(QV"TDP>'WD_6D1R'##V;CZ"&>BEWCL&&/@^MD!:% M>P``@`"``(U5F,:31W\7EGB1RW`!E#R00&`*DA^.ND\SD#.-8#TECI^,:BDB MC;:,70^+CL")D0``@`"``(S&F!B;]WZ:E<^9^&^"DXF7U%]ZD6"5N4Z>CW63 M\3REC>*2S2C/C-B2Q0]IC9V*:P``@`"``(Q5EYFDOWXBE5*B0V\`DP.?DU[V MD,V<\4X=CMR:U#PFC4^9W"AKC#B8&@]+C*R*5P``@`"``(P!ESVMQ'W#E/2J MW&Z1DIJGJ%Z"D%:DD4VTCENB43O/C,:@]2@?BZ^;(0\%CBH'AL_DB+G@YNF^-P6@A8G:]P M(```@`"``(,2I_)P9W7>I-9Q1V>MH>=R+%B!GR=S%D@PG*MS_C9GFL-TRR(K MFD=U'@B`FW1U,0``@`"``(*6II9X:'4_HXAXHFPFU1Y MH#8`F6=Y_B'KF,QZ%0B=F6=ZIP``@`"``((`I4*`4'20HCJ``&9?GTY_ME=. MG(Q_@D<&6UGCR&K5:?FWF%\4:6F/J%7#4;EP^%`B%:ED*%%`B\E=^#T0``@`"``(#8 MHTN07W-HH$Z/&64NG6&-RU85FIB,CT83F!*+B#3(E@>*\2$KE22+8@C,E&"% M\P``@`"``(!MHI"8AW+WGYF6SF2XG*B5`E6=F=J3346FEU&1\C1WE3R16R$5 ME!Z0Z`CBDPZ&`@``@`"``(`4HA2@TW+#GQN>N61^G!><;551F2R:.$50EI68 MIC07E(Z882#&DV^5?PCHD@"&!@``@`"``'_1H;RI7')]GK>F[&0NFZ:D,E3Z MF*VAI44"E@V@+3/9D_R>?""9DMB6"@CCD3N&`@``@`"``':TL\%G?VGUL#AI M"%R`K.5JC$X8J;QL`CZ'IN)M7"T]I.MN:QBYI9=N;`&)HJIP`@``@`"``'9: MLM!O4FG*KRAP'5Q7JZ9P^4WYJ%1QW3YPI5YRO"TZHTES:ACCHZ=S1@'^H#=U M80``@`"``'8,L7QVZ&E@K=AW&UP"JD=W8$V@INMWPSXHH^QX+2T0H<=XA!CN MH>EX5`)>G?EZ6```@`"``'6LL!U^76CIK'U^%EMWJ/-]W4TTI91]PSW'HIE] MQBS0H&I]T1CGH%I]O`*LF_I^KP``@`"``'5$KO2%X6A_JUB%+EL%I\^$ATRW MI&V#\SURH62#CRR0GS*#:QC9GO>#OP+MFCN!^P``@`"``'3DKA.-BF@HJG6, MH&B)FBQ?GAB):!C2G;:)@P,CF+:"'P``@`"``'24 MK665/6?FJ<&3REINIB.20TP8HJV0WCS4GYJ/[BPPG3N0!QC:G)6.60-6EVJ" M0@``@`"``'1=K->=`F>QJ2V;.UHRI8:95DO8H@:7HSR4GNR6M2OKG).6=AB[ MF\:0N0.)EE."9```@`"``'0NK'ZE%V>TJ+ZC&5HNI/R@T$NXH5V>R3Q[GBF= M\ROKF[Z;DQC1FO*0R`.LE8R"?```@`"``&HROP-FM%W.NT!H#E#CMY9I<$,C MM`5JQC0JL.AK]",?KSYLH@XAL4AKXP``GP1SL```@`"``&GMOCUN,EW/NCEN MV%#UMD)OG$-%LG=P;C1;KRYQ,2-SK4IQG`ZUKNAPY@``G! MFB.4J(6!G@^IJ3"!K@``FFR`````@`"``&E.N3R*NUT>M1R)R5!$L0"(W$*> MK0V($#/\J9&'DB.=ISJ'P`_FIZN&N```F9"`````@`"``&DIN'^1_ET4M$>0 MR%`_L!B/@D*4K!N.;#/QJ)N-X2.GIC*.11`BIEF*Z0``F-^`````@`"``&D- MM_.965T7LYZ7YE!$KUF654*2JTV5"#/DI\>4MB.#%SMLM<:>YQ5+A8:^=R9Z1M;;9S=X^? M;V=TAGGC<09UEV,^[ M9>*'4+3":`J&4*$;:@N%8(R::_*$AW<"N''PKD2 MA5ZE;2&0,T>";J:.*2UI;N:,Q0IH<82'"<.V8?VH$[#49$"DEYTJ9E6@^HB[ M:%2=:W.I:E*:$UW(;#.6_T;';;&45"S2;!48D;.J:_2Q/;-F87`FOB/BO&;`"< MJ`EM$)M^UQ:>2QO[D53 M>@]QNRL#>M]S&0>`?19S?;U&%UVY"HX>05WD`;U>UMX%+O`<"YZ:ZH^<7)ZMI?31[[$-S=M9\,BE8=TY\/P9Z>=9\;+HI;EV$RJB:;[*$ M,Y8Q<.R#EH+7!+@8/>(6`,;BN M;-&/*:)A%@:=$2& M>06T=V2#;+=X:Y:9FJ7T;/^7;9./;DV5(X!#;Y&2VFPP<-F0KU!7]);IJ:YFM';^N7 M^59@<2Z55D`^#/;!P M?/]DK*!-?1UG'8\1?51I5WR6?9QK9VC^??%M951$?E9O4SX1?M5Q#R0`?ZMR M)@'W@6=T`:]3>M%NH)\S>R=P$XW?>WIQ:'MU>]5RJ6?S?#ISXU-3?*]U%#TX M?2QV'2-#?-5XD9W@>4UY&8R^>;9YD7I+>B9Z`&;D>IQZ M=E)F>Q]Z[3QP>YU[3"*!:!SWCZ M>):!2>!)E%:>;R`Y3N/>CJ`HR'F>F2`5@%+?=%_NJMF=9>,0)L@=BJ+ M0(GE=K2*)7>Q=S^)`&2<=]>'ZU!F>'V&^SK'>/J&*R%)>.B%S`$@?AB`PZI/ M=&F6,IH)=0.4>(C1=9&2EG:D=B.0J6.A=L&.UD^2=V.--SH9=]^+^2"_=YB+ MM@#]?E6`JZEP=OH?J=*.;%G7!=36896+,==J5XD[;=H"3L3F* M=NN2*"!1=G.0S`#??H>`EZC*:>#C]=BR9$!_O=7J4]`#'?K"`AJA<H.&%S=':D@4VE=2*AL#A\=8.?AA]W=*B51@"T?M&`>:)_A<5D&9.@A19F MB8.7A)QHPG(_A$=JT5^XA`MLRDOQ@_)NK#:!A"!P2!QEA6%PY@``@$QVNJ&8 M@[AM@Y*G@T5O"8*`@NAP;7$U@I]QOE[#@FMS!$L7@EIT.S7`@GUU.!O(@V]U M9@``@`!ZN:"+@=EVU9%F@8AWBX%=@3MX*W`2@0-XP%W`@-YY54HX@-=YY#4% M@/-Z3QLW@9IZ+```@`!^.I]F@!F`)9`S?]V`(H`7?Z>``V\3?WE_WES;?V1_ MPDF`?V9_K31X?WY_E!K*?^%_5P``@`"``)X[?K")?8\D?GV(SW\'?E"'_VWD M?BN''5O6?AZ&2DB1?C*%F3.R?D*%#1HY?EF%#```@`"``)U$?9"2[HXD?661 ME7X*?3J0#VSR?1F.=UKU?0Z,^$?7?1F+L3,8+FPF?#25Y%HT?"Z3R4\>. MV0``@`"``)OE>_NE\XRV>]RC57R.>Z>@:VMW>WF=W&:R4:/>X.8PS(? M>VV7^1D@>L20_0``@`"``)M]>W^OGXPY>V*L;GO\>R&HV6K>>N2E/%C^>M*B M'489>N"@&C&O>L:=GQBX>?*0MP``@`"``)31CPQCDH;RC9UE\7?PC'EH(&>? MBXEJ)U8;BKML%4,]BBIMX2YVBBEO1Q/(C)MO%```@`!Z0)00C2UL>H8KB_=M M_G<.BN5O:&;+B?1PP%59B25R"T*1B)-S/RW?B'UT'A-BBGUSK```@`!]MI,Q MBU]U1X4(.@``@`"``(^HAF*8M8&:A7B7 M%W*%A(F5.6)G@ZF31E%M@O*1BC]5@F600BMO@?N0'1'E@AZ,&0``@`"``(\@ MA;RAOH$)A-F?EG'I@^&=&V',@O2:BU#5@C>86CZY@;*6]"KP@3J61A&R@1&+ M]P``@`"``(Z^A46J]X"7A&6H5W%C@V*E16$_@F*B(5!8@9>?F#Y6@0J>92J; M@(Z;-1%Q@$6+RP``@`"``(=\F)UC%7IIEIAE66Q$E.-G>%SADV1I,R'9RCZB+[V@_C@^*]%D8C(F)ZTD&BRZ( M_3>&%```@`"``(,FD'251'7QCMV3\&>\C3N28EB& MBZB0Q4AKBDV/:#<4B4*.F".>B+*.Q@K&B!V'20``@`"``(*QC]:=SG5VCD*< M!69[U@$BO:7S$?JB9.6&C:/B(R5:R,TA^F4%0JVAQ"'/@``@`"``(): MCV2FA'46CAQU>1BF>?+T>$B/>=4C8\A^6<<"+NASF7G@J5AD:' M*```@`"``'J0HJ5B<&X3H"9DE6"KG>YFH%(@F^=HBD)8FAYJ3C#BF/YKPQR! MF<%L/P/?F*%LO@``@`!_T'G\H4%J>VV@GLQKXF`TG']M05&YFEUNE4(!F(!O MTC"CETIPU!QFE\]Q!P0@EA!QT@``@`"``'EKGZ)R6&SNG4)S(5^=FO1SYE$A MF-%TK$&"EO)U:#!$E;%U_APVE@5U^P12D\5W30``@`"``'C$GA!Z'6PRF[MZ M85[-F7AZG%!\EUAZW$#LE8%['2_3E#Q[3QOWE&=[,01TDF#6!=D_(EA.!+4!HE#2`^"]DDN^`W!NUDO6`V`2.C_V` MG0``@`"``'>&F[J)WVKZF7.).%V3ES"(=4\ZE0F'K3_BDR*'!R\9D;F&L1N/ MD9V'%@2HCG:#)@``@`"``'<1FMV1UVJ`F)Z0Q%T5EEB/ADZZE"N.2#]MDD"- M3B[$D,J,]!N&D&6,I`3'C2F#.P``@`"``':SFD69ZVI+F`:8@US=E:Z6RTYS MDV&5##\>D663UBYCC_N3TALPCXR1/035C!R#10``@`"``'9KF=:B*VH"EXV@ M>UR+E2>>7$XH@-S`3?MG[ES MNB<;GG)T+A*2H!-SF```E:!X,```@`"``&RAJ.IX"&"OI@-X4U/]HRQXG$9J MH'IX[S>)GC-Y02;=G-QY;!*7GC)X]0``E#!\8P``@`"``&PHIY!_;&`XI*]_ M4%.!H=E_*T7CGR9_!#&\E_9HZ6&=U,EH,>%Y$6%G@N%4#;8FZN$Y29OFBB$U1*2FP.$N```D<:` M````@`"``&MDI;>.?5^1HM*-KU+?G^>,LD4ZG1Z+NS:&FKR+&R8[F26+2A*E MF:B)H0``D-N`````@`"``&LDI0^6$%]4HB:4]5*`````@`"``&KPI*&=XU]6H:28SR7\EVJ6YQ*JEZF,G@`+CXJ`"```@`"``&&SN'Q@B57TM7QB M4DFALI!D&#QAK\-EPRV[K8QG)1R2K41GN`A.`````@`"``%_] ML/R+%%2UK8V*?4B8JA^)O#N+IN&)""U=I#&(MATKHMZ)(`IEHDJ&B```C3.` M````@`"``%_9L%>21E2RK,N1?DB8J4B0=CN%I?F/B2U+HT&/91T8H>R.O`I\ MH1^'%P``C)R`````@`"``%_!K]V9H%2[K"R8O4BCJ)&7@3N'I326A"U2HFV6 M+1TSH0&33@J2H"*')@``C`"`````@`"``,$39Q5?[:[3:3EBM)OM:SYE8(@B M;21G[G-I;OAJ:5VW<+ELT4;')W)6R8J:(M8)I90R'EVY29V*& MCEDU:9"%IT+G:SF$S2F):QF$&@@4,'4(::>.*H"CE:7Z)L0?!/R@=\'R=N9PEQ$K'";"QIJZ%[;<]KC)``;U!M4'UK M<+UN_VG#`/A>7)UR;`Q:;5S])_-:WYT MWXY[;2!UN'OV;JUVC&AZ<#!W8%/M<:%X+CW^>MZ1JZ2 M9X)^'YXF:69^+8S::R%^+GJ5;,=^*6E-^*ZT099^(1YRS9YB'BXML:6F&NGDN:R"%X683;-&%%5'7;FR$9SQ+ M;Y*#QR,P;P:#4P,F>JV!@JO69!B2?9N`9A^0_(I!9_J/67@.:;^-KV4%:WJ, M&E#V;1:*KSN4;CJ)B"*@;5V)'P+Z>OF"`ZK<8MRS>!ZJHC8>RF[9G,8_ZC MZ8B$9=F@J'969Y^=8F-@:6J:84^`:Q27T3IN;"&6%B'):JJ3D`*W>VJ!UJFM M846Q'YE&8U2M6X?H92*I376Q9MRE16+%:**AI$[Z:DJ>MCGK:TJ<^B%/:8J6 MA0*?>Y.!Q:6D=Q5>PY9Z=Z]ANH8T>%QD='2G>11F^V'P>=-I9TX&>IMKMSB+ M>V9MOQ[+?#MNTP``@`!R8*1X='EHC95:=51JCH4!=B5L:7.+=O9N)V#N=\MO MU4TB>*-Q;#?#>69RQQXH>=AS40``@`!W!:,V!V4TQ&=L=W-C<1=X5W[1V==Y)X!P``@`![&*'$;_5[]Y*-<1=\ M3X)8^./G_X;Q.,]V[-<"R+G5R]<46*54F-Z5/VWP;PN3)UON<"Z1 M-$C<<3>/B#19<<6.<1N0<%V-6```@`"``)W$:I:BTXZ*:^.@5WY8;06=D6TU M;AV:O%LV;T*8*T@P<%*6&3/1<-25'QLZ;S61>@``@`"``)U4:?&LEXX(:SVI MU;XJ=`S-6;_^;>!K$;D>2&0``@`"``)A0 M?Y=>6HI)?W!A1GL8?WAC^&J6?YYF=EC8?]=HU47&@"YK#3#E@+YLWA:U@CUM M-```@`!V7)=3?1MGF(E&?3EII'H!?61KAVF1?9QM35?M?>-N_D3[?D%PCS`Y M?KUQR18V?[-QNP``@`!Z9Y8Y>M=POH@!>R!R`7CE>V)S)VAX>[!T-U;Z?`AU M.D0O?'!V*2^7?-MVV!7%?4AVA0``@`!]\Y4%>,1YYX:\>2IZ7>85ZVV=Y M>>%[.580>DY[CD-Q>L![W"\)>QM\"A5F>QU[I@``@`"``)/3=P>##H6N=W^" M\W:$=^J"L&9->%*"4E4?>,>!^T*6>4B!M"Y7>9*!=A3I>4V!4P``@`"``)+4 M=:2,2X2I=B:+AW6$=I>*D658=P:)@U0Z=WZ(@T'@=_:'KBW&>#"'+12!=\:& MI@``@`"``)('=(*5B8/;=0R4(W2W=7V2?&21=>Z0P5-]=FR/*4%!=N*-X2U: M=OR-4Q0Y=GZ+%@``@`"``)%JS(,W=#"&/G=0B8$U+7=8:5 M\T"A=@"49BS:=@>3_A/U=7>-?@``@`"``)#]A`=O4WP=@Z1PHVWM@T)QVUYW@O-R^DW?@KMT"SO8@K%T^B>S M@O=UAPV>@^=T[P``@`"``(A/@A1WZ'KZ@<5XEVRX@7AY*EV$@3)YJ$T`@0UZ M'CLC@0=Z@2)3WDV?MB( MTVL"?IN((UO"?EZ'5DN-?C>&ESG]?BR&"291?B2%V0T-?GJ$HP``@`"``(6Q M??.2$7AY?77UIY?&^58DI)?$:3LCC3?#22L26" M>^:22@S+?">(I@``@`"``(2X?'^CL7=T?&"AK&DO?!.?.%GV>[RX>: MK#AV>VN9X"4F>PR7(PR*>U^(>@``@`"``'Y#D?E=9G':D)%@&F1ICW%BIE6Z MCH-E!T6^C<-G.30?C7)I&Q_2CE9J%P9.CIEJ%```@`!\RWU[C^AEJ'$JCK!G MH&.RC9EI?U49C*1K0T4VB]QLY3.UBWUN11^.C"=NX`9JB_9N\```@`!_WGRN MC==MT7`ZC,5O(V+DB[QP8E1.BM!QCD2+B@URHS,NB:ESAA\VBB-SS`9WB9]T M*P``@`"``'O)B^UUZ6]$BNYVJF'>B?EW5%.%B1-W\4/7B%UX>S*CA_9XYQ[= MB$9X[09\AY)YOP``@`"``'KIBDI^!6YXB5A^1&$9B&M^9%*PAXY^:D-1ALM^ M;3(VAF=^=QZ=AHQ^8P:,A<9^KP``@`"``'HBB/J&1&VYB!:%^V!>ARJ%AU(+ MAD*$^$*ZA7R$<3'RA/>$(!YNA/F$.P:1A#R"VP``@`"``'F#A_2.C&TZAQJ- MSE_CAB>,RE%WA3"+IT(9A&F*LC%@@]Z*,AXI@Z.*B0:+@O.$;```@`"``'D$ MARJ6W6RYAE25L5]=A5F4)U#UA%62?$&:@X.1,3#4@OB0R!VX@IN/U@:)@>6$ M:P``@`"``'BBAI*?36Q2A;Z=RU[JA+B;QE""@Z69HD$V@L*8)3"&@B:7MAV! M@:^3\P9]@12$8P``@`"``'&OF]AD-EVK0"BC&MY M1```@`"``&[7E)M[D&,7DPQ[XE9QD8)\'4C0D`E\0SH2CL]\9REUCC%\?!6< MCPY\.@##BJI]I@``@`"``&XRDUN#6F)\D=:#/E7`EP``@`"``&VLDD^+)V'UD-6*H554CT6)Y$>S MC;^)%3D&C':(=BC/BYV(415UB^.(!`$#A]^`KP``@`"``&U"D8N3"F&QD!>2 M-542CGF1`4=IC-./L3B\BW2.TRAPBIZ/!!49BL>,H`$:AM&`O@``@`"``&SO MD/B;#F%?CWV9^%2YC=287T<0C""6L3ARBK&5T2@YB<65)Q3\B%4WPHB-@94"KH%MBC3'RGP5D:"#GGQ-EB@O[ MH;ME&@``C91MT@``@`"``&2SI,QC)UFFHHYD\4V3H&UFL$!LGGMH5C'2G/]I MOR#SG-5JB@Q/GOII_0``B_MRS```@`"``&0KHNAJ=5D,H+AKN$T9GI1L\3_X MG)IN'C%_FQ%O&B#0FL%OE0Q]G&QO!@``BGMWH@``@`"``&.=H0=QJUAKGN)R M>DQHG,ES/#]UFM%S]3$1F4ATC2"0F-YTPPR.FAET50``B11[Y0``@`"``&,. MGVYX\%?AG5-Y6$O>FSMYK3[CF3]Y[#"TEZEZ)R!-ERUZ,0R.F`%Z*@``A]%_ MG```@`"``&*0GBR`5E=QG!:`84MUF?B`2#Y\E_.`&C!5EDY_^B`EE:)_^`R5 MEAZ`$0``AK2`````@`"``&(FG2V'OU<9FQB'>4LDF/"&^#XHEMR&9B_ZE3*& M#A_FE&V&1`RLE'2%#0``A@``A2&`````@`"``&&5F\N6S5:_F:Z6 M)$K%EVR4[SV]E2B3K"^KDTJ39Q^QDEN1[PR_D>R(GP``A)R`````@`"``%DC ML:U:9$X:KU)JC6-B(Q63JV%B:`-%J;9C6@``B.=Q M_0``@`"``%APL&=A?4VZK>)C&T(CJVIDN35_J2YF.B```AF=ZW0``@`"``%>NK*=O.DS?JB9O_4%7IZAPN33G MI55Q;2;?H[QQ[!8*I$YQJP2$H5QR_```A4%^B@``@`"``%=2JOUV'$R*J()V MBD$$I?]VZC2*HZ9W,R:ZH?5W;18)HEUW*03"GP9XX0``A#Z`````@`"``%;_ MJ:U](TQ0IRI]2D#5I)U]3C1>HC=]/R:2H'1],Q8;H)=]%@3_G.]^%@``@UZ` M````@`"``%:ZJ*"$+4PIIA*$%D"YHW6#QS1!H0*#;"9TGS2#1Q8=GRV#AP4^ MFR&">@``@JV`````@`"``%:%I]*+0TP3I3**_4"JHH.*9S0RG_Z)SR9=GB&) MRA7_GA&)-@5-F:N#E@``@A:`````@`"``%9BIS22?DP,I'J2(D"GH;J1530N MGR.0I"9GG2^0F18FG/:-Y`5JF'"#J0``@8"`````@`"``+4F85-9LJ/^8]%= M`Y(V9B]@-W^&:'%C3&O>:I]F1E:D!O+D`U:_QQ!B<8;!)R M7@9C=35S0;%.6K%O`:"J7;-P2H]-8(-QC'S68R9RSFEN9:QT#53[9_YU0S\^ M:;MV5B91:65W"@87=;5X(J]T5^5Y@9[=6Q9YW(V,7@EZ.7M98-)ZEV@48W][ M`5/49>I[:SY.9ZA[Q"679MU[ZP75=B1\FJV^57B#\IU&6,Z#=8P$6^."]GG> M7L6">6;B88R""%+(9!&!KSUV95!N@0XD*5UJ=-W<,6F2:.V0W7527@%!X7_&5'CN< M88J35B..7VR1[`4F=TR#>ZG!3YBM=9F24S2IH(AX5FREN79Y67"A^&.P7%Z> MF5`$7OJ;Q3LH8'^:!2,B7D66'@4-=W>#:J@7:-M929AC:JE M8HAMCI5_9-EO#H4W9OMP>'.X:/]QU&$X:N]S)DV6;+AT:3B!;?UU?!^=;2YU M^0$4?BUX9:,T7]=WB)/58E!X,(.69)1XQW)?9KAY45_^:,UYW$R,:JIZ8S>K M:^9ZSQ[Z:IUZX0#]?E1\9J&H77^!?9)@8!F!78(M8GR!)G#^9+B`XE[H9N&` MI$N7:-2`=S;H:@.`2QYK:'2`'0#J?G5_U*!C6Y"+>Y$K7D**EH$)8+B)DF_I M8PF(@UWF94"'@DK)9S6&HS9#:%B%^!WN9JN%V@#9?I&`DY]?6?F5=)`R7+R3 MS(`:7SZ1^V\&89N0)%T18^*.;TH39=R,\S6_9N6+X1V/93.+C`#,?JB`BIZ= M6+N?88]S6XB<]W]97@V:6VY*8&R7OUQ:8KB584EH9+F3:34W9;*2-QTZ9`20 M-@#!?KJ`@IX=5]BI-H[J6J6F#'[#72.BIVVR7WN?3EO08<2<6$CU8\*:!S3# M9**8Y1S+8PV3>`"X?LF`?)LV<+)8]XS5<=\UK6@``@`!R'9GA;8=BC8NC;NYE#WPQ<$%G:6NC M<8QIH5GE^;FQXHT46;\)Y03#'<(EYMQ?*;^QY MC```@`!^<96@9<9_#H=G9Z9_/'@S:5Y_1F?X:OE_.5;&;(A_+$0Y;>U_*#`: M;IY_'A=2;@9^\```@`"``)1[8^J(DH9,9=^("G$OQ;I;'*$P```@`"``)./8F*2$H5E9&:0V'9&9C:/9F8A M9^V-XE4-:9*,?4+6:O2+5B\5:VJ*K!:=:R.)QP``@`"``)+>82Z;B82R8SN9 MH76.90Z7=65N9L.5.E1>:&V3/4(O:=*1LBZ3:BZ1)196:A6-Y0``@`"``))F M8$VD\X0N8EVB9W3[9"F?A&399=:.=8L8$G>5)<"7*W>>%?*&+^>H1B$U(!>S%DU#^=>^]G7BL\ M?,5I6Q#>?E!I8```@`!V"8U2=>%ANH`0=IED0'&<=U)FFV']>`]HTU$?>,]J MZS[=>95LTRJ?>D=N0!"(>X5M]@``@`!Z'XP=7![=.-N'6#E M=;MOHE`R=H]Q$CX:=UUR72H+=^US11`]>1!RRP``@`!]M8K5<)-SLGUK<:AT MP&\IDY=.%>FT.;O^%#%W'<`F$@DU_<0>#_SOC<=N#F2A; MR:RR.NGIU;'F-WFQ!;9R,PUT";JN+D4S&;["* M>SM(<'Z)IB?Z<'"):0\N`;R>/[`\`<5"*)0``@`"``(:7:22@LWE/:G^> MM&L*:YZ<45O0;*&9WDNG;9V7TCI%;E^6KB<5;@F590ZG<)&)Z```@`"``('7 M@8M87758@5A;EV?&@5I>H5CL@7UA=TC!@;AD&S<#@B=F<2+1@QUG^`CGA*1G MWP``@`!YELF@``@`!]!G^Z?`UI77,Y?%9K*67-?)=LV%<9?-QN9D:9QRG(.>@UR]V26>FAT!58N M>KMT]T9;>R!UTS47>X=VB"%T>]1VT`BR?7!W"P``@`"``'V`=XEZ2W#Y>`MZ MW&.,>'E[254L>-I[F46T>3][X32+>:E\&R$9>Z%\E@``@`"``'R/ M==>"WG`L=FN"WV+-=N&"K51?=T:"7$3E=ZR"$#/R>`*!WR"?=^.!U0B#>A^! M7```@`"``'O+='&+:F]F=1"*WF(,=8F*$%.E=?&)*$0T=EB(73-<=J"'V2!* M=CN(#PAR>-B%50``@`"``'LQ:_6#SLA3YILUL+A.EK9DTCA*%L^3WXA'AN9"T'A*%O?1D` MA9EOH`).A1-Q-@``@`"``')P@S]OWV:A@PAQ&5GV@L=R.$Q*@HQS/CTT@G!T M(RQM@HYTRAB<@S9TL@)=@PIVS0``@`"``'%]@4)WX&6Y@1UXD5D.@.IY(DM= M@+=YF#R9@)-Y_"OH@*EZ0AA(@/]Z$P)N@41[P```@`"``'"F?Y!_\F3O?W^` M(UA2?U6`)TJU?R&`##P'?OA_\"NS?NE_Y1@S?O-_Z`*-?[U_^```@`"``&_V M?CF("V1A?CJ'QE?/?@V'/4HK?0 M>[2+6P*??6J!Q@``@`"``&[]?%.82V-J?&"70E;3?"R5OTD[>]:4(CJ7>XV3 M$BI;>TF2_Q=1>G6/CP*0?*"!O```@`"``&D#E']7"EW0DTA9]U&NDE5J%T?D11@ M_5$)D"%C.$/,CU%E3C47CLQG'R0^CQQH6P]ID6UG^@``AB)N9```@`"``&=1 MC[9F-UQ`CLQG_5!0C>=IK4,CH)LZ0``A%YS MIP``@`"``&9^C7%MO%M>C)YN_T]BB\EP*D)EBP5Q/#/LBH!R("-OBIARG0\W MB\]R#@``@KQXF@``@`"``&6OBWUU3%J6BKQV%4Z;B?%VPD&>B2YW4#-FB)]W MR",#B*)W_0\,B5-WE```@4Y\Y0``@`"``&3WB>)\\%GNB3!]2TX`B&=]>T$) MAY]]C3+>AP1]F2+9ALQ]HP\+_]L`0P`%!`0%!`,%!00%!@8%!@@."0@'!P@1 M#`T*#A01%103$1,3%A@?&Q87'A<3$QLE'!X@(2,C(Q4:)BDF(BD?(B,B_]L` M0P$&!@8(!P@0"0D0(A83%B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B(B M(B(B(B(B(B(B(B(B(B(B(B(B(B(B_\``$0@`30"?`P$B``(1`0,1`?_$`!\` M``$%`0$!`0$!```````````!`@,$!08'"`D*"__$`+40``(!`P,"!`,%!00$ M```!?0$"`P`$$042(3%!!A-180'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?( MR;GZ.GJ\?+S]/7V]_CY^O_$`!\!``,!`0$!`0$! M`0$````````!`@,$!08'"`D*"__$`+41``(!`@0$`P0'!00$``$"=P`!`@,1 M!`4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)BH*#A(6& MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76 MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:``P#`0`"$0,1`#\`^R**X3Q1JUYH M7Q`\-W#W3KH]\);2>(GY!)MWHWU^4C\:\_T?QWK6GZ?XEOM6O)9O[0L'U'28 MG_Y9@RM&J+^<9_&MHT92C=&4JRB[,]Z/:EKQG_A:3^&H3IMZ(KV31HXHM1GN M+M4GED(!8QICY\9YZ5Z%XA\3+H>F:=?B`S6EUTN[ M:Q,,DL44B)?`W"E\#/EXZ`GN<^U-4:C=K![6%KW/2J*\RO?B3J%M+KL\&@^; MI>AW?D7=P;@*Q'R\HN.<;LG)%3Z3XG\17OQ6U'2YK*V&D0VL4J$3?,JL6P^- MO).!QGBE[*5KL/:QO8]&HKD=6\:1:)XAN['4(#'#%IS7T4^[B0*<,N/4_E:#1M`%Q=6MG'=7R2W/EB+S%W+&IP=SX!]!25.35[#=2*T/1Z*XO0 M?'MOXAU.S@L[=UBN]-^W*[G!7Y]A0CU!J]H7B2?Q#X/.JV-FHN&,JQP/)@$H MQ49;'&<>E#IRCNAJ<7L=-17DN@?$+6H_!=O>ZWIT=QJ%]?-9V,<,P_?/YC## M<`*%"]>H(.13E2E&]^ MA,:D96.LHKR.Q\8SV/Q3\3:);1RZAJ-Q=PFWMFDPD,0B7>Y)^Z.>PY-:.J?$ M74K.^\0_9-"%Q8^'F7[9<-<[2RE`QV+CD@$\'%-T97LA*K&USTNBO/[WQ[?3 M:G>V_AO1QJ":=;QSW$08.YMO/.![U57XJ6TEA>74=E(573HKZS0 MMAKCS"5"8[,'`7OUH]E/L/VL>YZ.[K&A9R%51DD]JS]/UW3-6DDCTZ\AN'B^ M\L;9(]_I7*V'B^/Q8FFZ9%:O&VJV,LUR=_-MM.PJ?4[LC\*M>&/!S:#JT]W/ M<+(75@%C4C)8@DG/T'`X%2X2RL5M8\C^\W2N>>-5"T;Z]$M65[)3UL!'_`.$DO-3TG5Y;!=0=9+N# M[.DJNP`&Y2PRI(`!KH=?T.#Q#X:O=)N69(KF+9YB#E#V8>X(!J=;QK<,EV07 MZC:*/[2)Y2%R*P>9TM.9V:Z6U7J4J#ULMSC_`/A5VG%O#A:\N&.B'+9`_P!* M^;?\_P#P,!N.]5[WX51W>HW\B:SQ$J"6Z.0E\"6TNB>)=.-W,(]>N&GE<*,QDA1@>OW M:L)X2:W\9QZY9ZC+"6MDMKFV\M6694SM.>JGD]*ZFBM>=]Q'Y_%? MB3P]8065R(K>?S;J]&!$(<'=&3W+$+Q6OJO@B2YUFZU'1M8N=*FOH5@NUAC5 MQ*J@A2-WW6`)&:[2BJ]I)))=`]FKMOJ<#+\-XK9M,?0-4N=+DL;0V19$63S( MB&;?2+>XEN(X2Q$LH&YMS%CG'UK>HI2J2DK-@H13N MCSZ/X:HFD/8?VQ=>5#>?;+!UC4/:2%BQP?XAECU[5M>'O"O]C:E?ZE?:A-J. MIWRHDMQ(BH`BYVJJC@#DUT]%#J2:LV"A%:I'!ZA\-;.]UV_UB&_N+75;BYCN M(;J)1N@*H$*CU5@.0:NR^"()]/\`$]M+>2D^(1^^<(/W?[L)\OY9YKKZ*/:2 M[A[./8X.Z^'K?:IIM'UR[TTW=M';7@BC1Q,J+M##/W6QQD4ZY^&>E37/AEX9 M9H(_#ZA(XEP1,H((#_\``E#?6NZHH]K+N'LX]CD_#G@FS\.:_K&I6T\LKZE) MN$;@;8!DL57V+,3^-=9114RDY.[*45%61QNL:GXFTN>>:31K;5-+1MRK92%; MA5_W6X8_0BKOA?QIHGBN!_[&N@9X>)K61=DL)]&0\BND`XKP7XW^')_#@M_B M#X3;['JUA*HO#'P)XR?XAWYP/H:THTZ=2?*U:3Z_YF524H+F6J1[>US9G4%M MFEA^ULN\1%AO*^N.N*H:QXALM'\N.4M+=S'$-K"-TDA]AZ>YXKY^O?$]U+?Z M1XOMM2CEN-3;SK/2[>(^:S%0FV1S_`I!P!UKV;P3X7GTZW;5M?D^U>(+X;IY MFY\L=HU]`/:M98.%&/M)]>G5O_+S,5BG5GR4^F[[+_,Z/2I;^YMWDU6VAMV9 MODB1MQ5?]H],_2M/H**YOQQK3Z!X(U.^MQFY6+9;J.K2-\J#\R*YHP3E9+AA^!?B-;>,_$GB73(EC1M(NO+B*G/F1]-W_`'T#^E=_BOA7X+^(KCPA M\:;:#4F:-;R5K.[#'HQS@G_@6*^ZQS75C<.J-2RV:.?"UW6C=[H****Y#J#M M28I:\ZN?&7G_`!ST[PQ8W.8H+"::\C7&"YV[`?<#)_&JC!SO;IJ3*2C:YZ+1 M114E!1110`4444`%%%%`!7&_$R&TG^&NM1Z@)#:F'+K&/F;!S@?7UKLA7G?Q MFOOL/PMU([G5IBD0*-@\G^5;X6//7A'NT<^*GR4)R[)G@_P[U13\0=)O+Q(( M%>811EU!"KC"HBG[H'3-?7@Z5\7S^&K[PMI7A;Q-,,QW4@?RVS\I5LC\",5] MD6BQ\1@_5S_P".UWG05Y-I$WB34O&WB/7=`L]+N;.286,$E[136[['LU'LCYV^/\`X)_'[P]XHUSP.FJZOIND1) MI#^8TEG7$FV\O\!C"`"S*HZ9"CK6 MOXM\*:MX<\)WVL>'/$NKG4]/A:'(UO('A+B\F)7<" M,_ZOWJ,116'G"*MMKYETJKJQE)WWT.2\&>-)/C'X5DV:U>:'JU@A%W!8%0)` M1PXW`D"O$?@SIMYK7QLNHEUB^M;I4G8WD1#2-@X.=P(.:]3^%?P6\4_#SQ?+ MJFH7^G26$EK)%-%;R.6;(RO!4#@@5P'[/?\`R7V]_P"N5S_Z%6\?9QC5]F[J MVAC+GE*G[16=SZ@;POJ?]CBU'BC5!.LID^U;(MY&,;?NXQWZ5\N>%_B]XM'Q M2@MM4U*\U&WAN)(8[.-0#._*HIP.YQ7V>_W3]*^&OA.BG]I*V4J"!?7&`?;= M7/@5&<*CFKV1MBKQG#E=KL^G%\%:]K]O]L\2>)M2L[N4;EM-*D$44'H,X)8C MU->7?#[XI:YHOQ?N_`_BB^;4K4W;VMO=2C]XK`G;D]P>*^FZ^&[G_D[8_P#8 MPC_T8*G!I5U.,UHE=>16);IN#B^I[Q\:/BU/X)O+#1-(>."_O@'ENY$WBWB) MQN"]SP?RKI+'P*=0T."\7Q=K\]Q MN>-M3?37MT\L.D@!E4'.W&"3U/3UK9T7Q_:3:+:P^%/#6NWVFV\2Q03);K&A M11@8+L"1@>E9.WLH^S6O5_\`!+5_:2YGIT.#^&7Q=U:Y^(%YX)\4O'=7<4LL M5K?!=I=DSPX''('6NX\*IXE7Q/(VHF\:-@?-$RD(IP>A(P><8VYXKYM\!S/< M?M50320O`\FI3LT4F-R'#<''&:^WZTQL(T9)17Q)$X6S(=O]*[!E#1D,,AA@BL'PKX;MO"^FS6=E)(\, MMQ),`_\`!DYP/:G[52H.#WO=?J)TN6NIQVM9_H+XQUG^P/!NIZ@O^LBA(B'] MYS\JC\R*3P?I(T+P9I=@W^MA@7S3_><\L?Q8FN;\5_#NY\6O_IOBC4X;,3": M.UA2,*C* M+C=?V6?&9,/W?/\`[-C\['^]NQGWQ48FHL0U*^J5F50C[%-=&[F]JNOW4_C: MUT/2F1HX;>2XU%MN=BE2$3/8EN?H*^9?V?AM^/UZ&X/E7(P?]ZOJ[P[X8L?# M=E+%9^9+-,YDN+J=M\L[]V9O\XKS#6?@Y;:9XX'BOPCK%QHNH3NS.B0K+'EO MO<$C@YZ4\/5A&,Z7=;A6IR)K^37+A-K:@(HP5C'_+-$P54$\G'- MGAJD*4)Q;W5B:\95)0:Z.Y M[E7PY<_\G:G_`+&$?^C!7V-)I-]-X<2QCUJZBO`%!U`1H9#SD_*1MYZ=*\I; M]GC3&\4?VXWB+5CJOVC[3]HPF?,SG=C&.M+!U84>?FZJQ6*A*?+;H[GB'CC4 MY_$W[20MO$#M]B@U..U6)S\J1A@,8]^OXU]N1I';VJJ@5(HTP`.``!7BGC?X M$Z9XBVZI/J]Y'K&(/#]M.6N)[Z^O&#W5Y
-----END PRIVACY-ENHANCED MESSAGE-----